The sixth edition of the Pharmanews Young Pharmacist of the Year has commenced with nomination exercise for qualified candidates for the online competition.
The award is for the recognition of young pharmacists who have distinguished themselves in the provision of innovative public healthcare services to their immediate communities.
Pharmanews Limited, Organisers of Dean of the Year Award, Outstanding Pharmacist of the Year Award and PANSite of the Year Award, birthed the Young Pharmacist of the Year Award in 2018 to encourage innovation and active involvement of young pharmacists in public healthcare and community health outreaches.
The maiden edition of the Online Poll saw Pharm. Isa Muhammad, as the winner, while Pharm. Frank Eze won the second edition in 2019, Pharm. Dan Eze, was the winner of the 2020 contest, Pharm. Ozioma Onyedikachukwu Ezeofor won the fourth edition in 2022, with Pharm. Uwem. O. Ebong emerging winner of the 2023 competition.
To qualify for this prestigious award, the prospective candidate must meet the following criteria:
Must be a registered pharmacist in Nigeria
Must be a young pharmacist not older than 35 years of age
Must be actively involved in public health advocacy
Must have demonstrated innovation in healthcare delivery
Must have been engaged in drug research and development – especially towards combatting any infectious disease.
Must have personally undertaken other community development activities.
We hereby urge you to nominate young pharmacists who meet the above requirements.
Please mention your nominee as a comment to the post.
Sequel to the nomination exercise, a specially constituted screening panel will conduct background checks on nominees with the highest nominations. Thereafter, qualified candidates will be shortlisted for the Online Poll. The candidate with the highest votes becomes the winner of the coveted award.
Please note that nomination closes on Wednesday, 13 November, 2024 at 12 noon.
N/B: Previous winners are not qualified for nomination again.
The Pharmaceutical Society of Nigeria-Young Pharmacists Group (PSN-YPG) has congratulated Pharm. (Sir) Ifeanyi Atueyi, publisher and managing director of Pharmanews, on receiving the prestigious Professional Leadership Practitioners’ Institute Award. The award, presented on 7 November, 2024, at the University of Lagos, recognises Atueyi’s transformative leadership in health and wellness innovation.
In a statement signed by the PSN-YPG National Editor-in-Chief, Pharm. David Friday, the group described the award as a testament to Atueyi’s unwavering pursuit of excellence through innovative leadership. The PSN-YPG highlighted his remarkable contributions to the Pharmacy profession, which have inspired countless practitioners and advanced the sector.
The group also announced a new partnership between PSN-YPG and Pharmanews, aimed at amplifying the voices of young pharmacists and providing a platform to showcase their initiatives.
Expressing gratitude for Atueyi’s consistent support, the PSN-YPG group affirmed their commitment to advancing the profession under his mentorship and guidance.
-Honours Atueyi with Distinguished Personality Award
L -R: Pharm. Mercy Adeolupo; Pharm. Eseosa Osemwegie; Pharm. Sanusi O. Musbau; reading their oath of allegiance to graphopharmacy practice during the graduation/ induction ceremony at Pharmanews Head Office, Lagos.
The journey of graphopharmacy in Nigeria has witnessed an astonishing turning point as Macdiptoy Consulting Limited inducted its first batch of graphopharmacists. The event, which was held Thursday, at the Pharmanews Ltd head office, Maryland, Lagos, combined a graduation ceremony and induction, showcasing the pioneering integration of graphology into pharmacy practice for better healthcare delivery.
Graphopharmacy, a concept pioneered by Pharm. Macjob Oladipupo employs handwriting analysis to detect and address health concerns, reforming preventive healthcare in Nigeria. In his presentation at the event, Oladipupo underscored the potential of graphopharmacy in transforming community pharmacy practice, citing its therapeutic value in improving conditions like stroke recovery and mental health.
He further explained that graphopharmacotherapy involves the use of certain tools, that is, writing certain things to help a patients’ condition.
“You can write certain things which we call tools in graphopharmacy. Certain tools can be written that can even help patients that have suffer stroke.”
“If you get stroke patients to write more, you’ll be seeing the improvement in their health as the handwriting smoothens.
Pharm Macjob Oladipupo presenting the Distinguished Personality Award to Pharm.(Sir) Ifeanyi Atueyi, during the induction ceremony.
The graphopharmacy pioneer asserted that writing stimulates the brain, and could result in longevity in elderly persons. “One of the things we have found out is that the chances of elderly people living longer are more if they are encourage them to write.”
“If you want your elderly people to stay longer, encourage them to write more. Get them to write more. It is an activity that stimulates certain areas in the brain.”
Pharm. (Sir) Ifeanyi Atueyi, the chairman of the occasion and publisher of Pharmanews, was honoured with the Distinguished Personality Award for his lifelong contributions to Pharmacy and Journalism, particularly his mentorship to the graphopharmacy pioneer.
The Octogenarian Publisher, described the initiative as historical and praised Pharm. Oladipupo for leveraging his God-given talent to birth such innovation. “No one has ever done this before in Nigeria. Your determination and resilience have made this possible,” he said.
Reflecting on his path to greatness, he emphasised the need for excellent service as that was his stepping stone to success. “ Nobody can beat his chest and say I made myself.
“I’m thankful to God for who I am today, I thank you for honouring me today”.
The ceremony saw the induction of three Fellows as Nigeria’s first graphopharmacists: Pharm. Adeolupo Mercy Tosin; Pharm. Eseosa Osemwegie; and Pharm. Sanusi Abayomi Musbau. Speaking on behalf of the Fellows, Musbau highlighted the programme’s impact in equipping pharmacists to address health issues with greater precision, while Pharm. Tosin expressed her pride in being a pioneer inductee and her commitment to advancing healthcare outcomes.
The ACPN Chairman, Lagos Chapter, Pharm. Tolulope Ajayi, who was the guest speaker at the occasion, commended the initiative as a ground-breaking step in pharmacy practice and urged the inductees to continually seek personal and professional growth.
“Congratulations on being inducted as the very first set of graphopharmacists in our dear country. It is a unique feat” he said
He continued, “I want to encourage you, please don’t rest on your boars. Keep the fire burning. Keep charging yourself and keep developing. Learning is lifelong. Every avenue and every opportunity to develop, we must embrace it. The truth is we won’t stop learning until we leave this world.”
The Representative of the ACPN National Chairman, Pharm. (Mrs) Mary Omokhafe Ashore, praised the programme’s alignment with global healthcare trends and its focus on holistic, preventive care.
“This proactive solution demonstrates how we can approach healthcare management from a holistic and preventive angle, aligning with the global trend toward integrating health. By studying the unique energy patterns manifested in handwriting, graphopharmacists can identify red flags indicative of both current and potential health challenges. This early detection approach could transform how we diagnose and respond to health concerns promoting wellness in ways that extend beyond conventional methods.” She noted.
she urged the Fellows to stand firm at the frontiers of healthcare delivery. “Your expertise will undoubtedly enrich our healthcare system and offer unique perspectives to your communities, advancing not only individual health but the collective well-being of our society.”
“ I encourage each one of you to continue developing this expertise with humility and commitment. As pioneers, you hold the responsibility to uphold the highest standards in practice, to educate, and to inspire others within and beyond our profession. I am confident that you will uphold this responsibility with excellence.”
A solemn oath swearing marked the induction, which highlighted the ethical standards of precision, care, and confidentiality in graphopharmacy. Oladipupo announced plans for the next training session in March 2025, underlining the need for wider awareness of the practice.
In a landmark partnership that will expand access to essential medicines in Nigeria and West Africa, Swiss Pharma (Swipha) Nigeria, has secured a huge sum of $2.3 million commitment from the United States Agency for International Development (USAID) for the procurement of 4.8 million doses of life-saving malaria tablets.
This was disclosed through a statement from USAID, made available to Pharmanewsonline .
Recall that USAID Nigeria executives recently visited Swipha over its historic feat on the attainment of World Health Organisation (WHO) prequalification for its product, Sulfadoxine plus Pyrimethamine (SP) 500/25mg tablet, and pledged to patronise Swipha on the product.
Pharmanewsonline reports that USAID’s commitment to Swipha for the procurement of 4.8 million doses of life-saving malaria tablets, is in fulfilment of its promise to the pharma giant.
The project, to be facilitated through the U.S. Government’s President’s Malaria Initiative (PMI), underscores the United States’ dedication to advancing Nigeria’s healthcare infrastructure and ensuring life-saving treatments to reach vulnerable communities.
For years, Nigeria has faced significant challenges in procuring affordable, high-quality medicines due to the high cost of production and the inability of many local pharmaceutical companies to meet international quality standards.
According to the World Health Organisation (WHO), fewer than 10 percent of medicines manufactured in sub-Saharan Africa meet global standards, limiting local companies’ ability to supply essential drugs and meet healthcare needs. These barriers have particularly affected access to medicines for malaria and child health, as local production has often fallen short of both quality and quantity requirements.
In response, USAID’s Promoting the Quality of Medicine Plus (PQM+) programme, implemented by U.S. Pharmacopeia (USP), partnered with Swipha in their efforts to attain World Health Organisation (WHO) prequalification for sulfadoxine/pyrimethamine (SP) tablets, a vital medicine for malaria prevention during pregnancy.
Swipha is now the first pharmaceutical company in Nigeria and in West Africa to achieve this WHO certification, marking a critical step forward for the region’s pharmaceutical capacity.
According to Swipha Managing Director Frederic Lieutaud, “USAID’s support was pivotal in helping us reach this milestone. The WHO prequalification not only validates our commitment to producing high-quality medicines but also enhances our capacity to scale production and serve both local and international markets with trusted, essential medicines.”
He noted that with the WHO prequalification, Swipha is well-positioned to expand its reach, supplying these essential medicines to international donors and procurement agencies, ultimately strengthening healthcare delivery across Nigeria and the broader West African region. This achievement also represents a significant boost to Nigeria’s healthcare system by enhancing local manufacturing capacity and contributing to public health efforts to combat preventable diseases.
During her visit to Swipha’s facility in Lagos, USAID Mission Director to Nigeria, Melissa Jones, remarked, “This achievement is a testament to the power of collaboration in improving healthcare in Nigeria. We are proud to have supported Swipha in reaching this milestone and look forward to continuing our partnership to ensure more quality medicines reach those who need them most. Together, we are building a healthier future for Nigeria.”
In July 2014, I was in Dubai for an international workshop on healthcare financing and innovation. The workshop, which was organised by Pharmanews Limited in collaboration with Aster DM Healthcare, was attended by medical doctors, pharmacists, and nurses. The visit to the Aster DM facilities and the city tour made the event very memorable. Two key messages of the workshop were teamwork among healthcare personnel and commitment to the welfare of the patient. Healthcare personnel generally were urged to respect, serve, help, encourage, and exercise patience with the patient.
We were challenged to learn from the service industry that does everything to provide good service to the customers or consumers. However, one major obstacle to such admirable and patient-centered kind of care was identified as ego, the feeling of superiority, and self-importance, which results in poor services to the patient.
Today’s healthcare, as the workshop facilitator observed, demands capacity development and continuous training of personnel. Effective hospitals can no longer be managed by doctors alone. As the hospital grows, there is need for hospital administration, pharmacists, business managers, accountants, technologists, and so on.
On our way back from Dubai, I had some time at the airport and as usual, visited some bookshops. This time, one of the books I bought was titled, “Live Life Like Never Before” by Shukla Datta. I started reading the book at the departure hall. In the process, I came across a touching story that I would like to share here with you. One day, a doctor entered the hospital in a hurry after being called for an urgent surgery involving a boy.
He immediately went to the changing room, got ready, and went to the surgical block. He found the boy’s father restlessly walking in the hall, waiting for the doctor. On seeing the doctor, the father yelled, why did you come so late? Don’t you know that my son’s life is in danger? Don’t you have any sense of responsibility? The doctor smiled and said, “I am sorry. I wasn’t in the hospital.
I came as fast as I could after receiving the call. And now, I want you to calm down so that I can do my work.” “Calm down?” The man asked angrily. “What if your son was facing life and death right now? If your son dies right now, what would you do?” The doctor replied with a gentle smile on his face. “I will quote from the Bible, from dust we came and to dust we return. Doctors can’t prolong lives.
Go and meditate for your son’s life. We will do our best by God’s grace.” “Giving advice when we aren’t concerned is so easy,” mumbled the father. The surgery took a long time, after which the doctor came out happy. “Thank goodness, your son is saved,” he said. And without waiting for the father’s reply, he left the place as hurriedly as he came. Minutes later, the father went to the nurse attending to the boy and asked, “Why is the doctor so arrogant? He didn’t even wait for me to ask about my son’s condition.” The nurse could not check her tears. Her voice was choked.
She struggled for some time and then said, “His son died yesterday in a traffic accident. He was at the funeral when we called for him for your son’s surgery. And now that they have saved your son’s life, he left running to finish his son’s burial.”
I don’t know whether this is a true story or not. But this can never happen in Nigeria. Nigeria is not a place where a patient can have the courage to yell at the doctor for coming late to work. A patient may not even be bold enough to ask for the name of the medicine prescribed for him.
No patient can challenge his doctor, who is the almighty in the hospital. No doctor can be so humble as to apologise to his patient for coming late. And definitely no doctor in Nigeria can be so committed to his patients as to leave the burial of his own son to rush to the hospital on call to save another man’s son.
…As May & Baker increases award’s cash reward to N1.5million
Professor Oluwatoyin Odeku
A former Dean, Faculty of Pharmacy, University of Ibadan (UI), Professor Oluwatoyin Odeku has won the 2024 edition of the prestigious May & Baker Professional Service Award in Pharmacy.
She was announced the winner of the award at the closing bouquet of the 97th Annual National Conference of the Pharmaceutical Society of Nigeria (PSN), held from 4-9 November, 2024, in Uyo, Akwa Ibom State.
Meanwhile, pharmacists in academia have dominated the award in the past four years, winning it back to back in 2021, 2022, 2023 and now 2024.
Management Staff of May & Baker Plc and the Award committee displaying the Cash Prize Reward of the May & Baker Professional Service Award at the closing Banquet of the 97th PSN conference, Uyo.
A former National Chairman of the Association of Pharmacists in Academia (NAPA), Prof. Martins Emeje, clinched the award in 2021 in Port Harcourt; Deputy Vice-Chancellor, Academic, University of Benin, Professor Ray Ozolua, won the award in 2022 in Jos. Prof. Emmanuel Chinedum Ibezim, of the Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka emerged the winner of the award in 2023 and now Professor Oluwatoyin Odeku of Faculty of Pharmacy, University of Ibadan (UI), has won the 2024 edition.
While announcing the winner of the award, the chairman of the award committee, Pharm. Anthony Oyawole, who likened the award to the “Nobel Laurel”, noted that the May & Baker Professional Service Award in Pharmacy was instituted in 2005 by May & Baker Nigeria Plc.
He stated that the award was meant to recognise outstanding achievements and contributions by individual practitioners, public servants, industry operators, academicians/researchers in the study and practice of pharmacy in Nigeria.
The award committee chairman expressed profound appreciation to the management of May & Baker Nigeria Plc for sustaining the award since it was established till date. While commending pharmacists in academia for dominating the award, Pharm. Oyawole urged pharmacists in other practice areas to be innovative in their practice so that they can win the subsequent editions.
In his remark, the managing May & Baker PLC, Pharm. Patrick Ajah, commended the award committee for a job well done over the years. He also commended all the past winners of the award, saying their contributions to the pharmaceutical industry in Nigeria remain indelible.
Meanwhile, the cash value for the award, which is currently N1 Million will be increased to N1.5 Million from the next edition. While announcing the increment of the cash value, Pharm. Ajah said, the value was once N500,000 but was increased to N1million, he averred that in view of the inflation rate in the country, the cash value will be increased to N1.5million from next year.
The managing director added that May & Baker will also partner with the winner of the award henceforth, especially the academia by sponsoring their research works and also ensure that the outcome of the research will be transformed to finished products that will be produced in commercial quantity and make them available in the market.
While speaking to Pharmanews on the award, professor Odeku commended the management of May & Baker for their consistency in recognising valuable contributions to the pharmaceutical sector.
She said “I count it a great honour to be the recipient of the 2024 May and Baker professional service award. I am grateful to God and my family for their support. I appreciate May and Baker for consistently recognising contributions to the profession of pharmacy over the years. I wish May and Baker continuous success”.
The May & Baker Professional Service Award in Pharmacy is one of the most prestigious awards in the Pharmacy profession in Nigeria and prominent pharmacists have won the award over the years.
The past winners of the award include Pharm. (Lady) Adaeze Omaliko, managing director of Malix Pharmacy, Onitsha; Professor (Mrs) Mbang Femi-Oyewo, former deputy vice chancellor of Olabisi Onabanjo University; Pharm. Ifeanyi Atueyi, managing director of Pharmanews Limited; Pharm (Mrs) Margaret Obono, a Fellow of the Pharmaceutical Society of Nigeria (PSN); and Pharm. Folashade Lawal, a renowned community pharmacist, among others.
L – R; Director-General NAFDAC, Professor Moji Adeyeye; Comptroller-General of Customs, Bashir Adewale Adeniyi.
In a landmark move towards safeguarding Nigeria’s public health and national security, the Nigeria Customs Service (NCS) and the National Agency for Food and Drug Administration and Control (NAFDAC) have formalised a strategic partnership with the signing of a Memorandum of Understanding (MoU) .
The MoU was signed on Thursday, 14 November, 2024.
The event took place on the second day of the ongoing Comptroller-General of Customs’ 2024 Conference held at the Congress Hall of the Transcorp Hilton, Abuja.
The historic event aims at strengthening collaboration in combatting the influx of illicit pharmaceutical products and other harmful substances into Nigeria.
Comptroller-General of Customs, Bashir Adewale Adeniyi described the agreement as the culmination of years of dedicated dialogue and coordination between the two agencies.
Highlighting the critical mandate of the Customs Service in safeguarding national security, public health, and safety, stating, “What we have seen today is a culmination of efforts for several months—I must say, years—of regular consultation between the two of us. This partnership is a response to a major scourge we are facing in the country.”
Emphasising the specific provisions of the MoU, Adeniyi noted that Article 2 of the document outlined a comprehensive scope of collaboration, particularly in intelligence sharing, adding, “We’ll be talking about the exchange of intelligence between our agencies.
CGC Adeniyi further said, sometimes, at midnight, NAFDAC DG sends intelligence to me, saying, “We learn that a suspicious container may be birthing in the morning. This kind of real-time information flow is critical to our joint efforts.”
Reflecting on the collaborative bond that has grown between NAFDAC and Customs personnel, CGC Adeniyi emphasised the hands-on commitment shown by officers at the nation’s ports and border stations.
He said, “When we declared a state of emergency in one of our ports, we were misunderstood, but the reports we have received indicate we are just scratching the surface of illicit pharmaceutical products entering our markets. It is time for all of us to say, collectively, that this will be the beginning of the end. We are going to save Nigeria and the future of our kids from these dangerous products.”
Speaking earlier, NAFDAC’s Director-General, Professor Moji Adeyeye, described the signing of the MoU as a “significant stride”, pointing out the daily impact of the products regulated by her agency on Nigerians.
She said, “It is important because of you and me,” Adeyeye explained. We consume at least two of our regulated products every day—food and healthcare items. This partnership is about ensuring that the food, drugs, and healthcare products we take are safe and of the highest quality.”
Professor Adeyeye highlighted the threats posed by unregulated and illicit products to national security, as some approved chemicals can be misused by criminals and terrorists, adding, “This is of national significance.”
She lamented, “We have ghost companies that are not on our lists. This MoU marks the beginning of the end of such practices.”
Adeyeye further expressed gratitude for the close partnership with Customs officers, affirming that the initiative transcends individuals and agencies, stressing that, “It’s not about NAFDAC; it’s not about Adeyeye or Adeniyi. It’s about saving the future of our country.”
From L-R: Joseph Onyeanu, senior clinical research associate, Xcene Research; Adebusola Balogun – director of communications, Xcene Research; Toyin Adesola, executive director and founder, Sickle Cell Advocacy and Management Initiative (SAMI), and Timi Edwin, executive director and founder, CrimsonBow Sickle Cell Initiative, at the IAS 2024 press conference.
The Impact Africa Summit 2024, organised by Xcene Research, will convene in Lagos from 19 to 21 November, drawing over 500 key stakeholders from the pharmaceutical and healthcare sectors to drive Africa’s participation in global clinical trials. Themed “Expanding the Pharmaceutical Value Chain through Inclusion of Sub-Saharan Africa in Global Clinical Trials,” the summit aims to build Africa’s capabilities as a clinical research hub, advancing healthcare innovation and economic growth across the continent.
In anticipation of the summit, Xcene Research has held a press conference at the Marriott Hotel, GRA Ikeja, highlighting the forthcoming summit’s role in positioning Sub-Saharan Africa as a pivotal player in global clinical trials.
According to the organisers, the summit is expected to convene over 500 stakeholders from the pharmaceutical and healthcare sectors, as it seeks to establish Africa’s capabilities as a clinical research hub, fostering innovation and economic growth across the continent.
In her opening address, Mrs Adebukunola Telufusi, executive director of Xcene Research and the summit’s convener, emphasised the vast potential Africa holds for clinical trials due to its unique population and healthcare landscape. “With strategic investments in training, infrastructure, and regulatory harmonisation, African nations can conduct world-class clinical trials,” Telufusi noted.
Telufusi, who was represented by Adebusola Balogun, director of communications, Xcene Research, underscoring the opportunity for Africa to meet global standards and contribute significantly to healthcare solutions.
According to Dr Faramola Oguntoya, project manager at Xcene Research, the event serves as a platform for collaboration and advancing healthcare in Africa. “This summit is a pivotal step towards a healthier, more inclusive future for all, as it fosters partnerships and shared solutions,” Oguntoya remarked.
“The summit will feature workshops and discussions covering diverse topics including hematology, nephrology, patient advocacy, and regulatory frameworks, with sessions designed to bridge health equity gaps and promote sustainable healthcare industrialisation”.
The organisers have described the event as a transformative opportunity to empower Africa’s healthcare sector through an inclusive and collaborative approach to medical research. The summit’s agenda has attracted widespread attention, with stakeholders anticipating meaningful strategies for Africa’s advancement in global health research and clinical trials.
While responding to questions on the challenges facing sickle cell research in Africa, partners of Xcene Research, including Timi Edwin, executive director and founder of CrimsonBow Sickle Cell Initiative, said the lack of funding as a major barrier, saying sickle cell itself is an expensive condition to manage, and without infrastructure investment, research is hardly prioritised.
She however applauded Xcene Research for creating a space to network and overcome bottlenecks, adding that corruption also remains a significant challenge. “No sensible organisation would budget bribery. I hope events like this continue to break down these barriers and push research to the forefront,” Edwin stated.
In her contribution, Toyin Adesola, executive director and founder of Sickle Cell Advocacy and Management Initiative (SAMI), also weighed in on the cultural and structural challenges hampering research participation. “Cultural superstitions and fear around medical procedures make it difficult to collect accurate data on sickle cell prevalence. People hide due to stigma, making it challenging to involve patients in clinical research,” Adesola noted.
She stressed the need for policy reforms that classify sickle cell as a disability, helping to reduce stigma and improve quality of life for affected individuals.
According to the organiser, the Impact Africa Summit 2024 is expected to have participants from across the continent and beyond.
As anticipation builds for the Impact Africa Summit 2024, stakeholders see the event as a crucial moment for Africa’s advancement in global health research and clinical trials.
L-R: Pharm. Ibukun Adetuyi, head- digital marketing Mega Lifesciences Nigeria; Dr Binu Joy, CEO Health @Home, Digital Division, Mega Lifesciences Global; Amit Raghuvanshy, business head, chronic care division, Mega Lifesciences Nigeria; and Ijeoma Ireigwe, product manager- diabetes, Mega Lifesciences Nigeria, at the 45th Endocrine and Metabolism Society of Nigeria Conference, Abeokuta Ogun State.
In celebration of World Diabetes Day 2024, themed “Diabetes and Wellbeing,” Mega Lifesciences has launched the We Care Diabetes App—a pioneering mobile platform aimed at transforming diabetes management across Nigeria. This launch comes at a crucial time, with diabetes becoming a growing global health crisis, particularly in Nigeria, where over 11 million people live with the disease.
Diabetes mellitus is a condition that arises when the pancreas fails to produce sufficient insulin or when the body is unable to effectively utilise the insulin it produces.
The World Health Organisation (WHO) describes diabetes in Africa as a serious, chronic and costly disease that is estimated to rise to 23.9 million cases by 2030. The global health agency recent survey estimated that 15 percent of Nigerians are living with diabetes mellitus. And the major symptoms of diabetes include increased thirst, frequent urination, and increased hunger.
There are three different types of diabetes namely type 1, type 2 and gestational diabetes. Being a silent condition, that develops gradually, a significant number of people are unaware that they have the disease.
The We Care Diabetes App, according to the pharmaceutical company, is designed to provide real-time support to diabetes patients. It enables users to monitor their blood glucose levels, access professional health coaching, and store their medical history, all through a user-friendly interface. By offering advanced remote care, the app addresses the pressing need for accessible healthcare, especially in rural and underserved regions where such services may be limited.
The app was unveiled during the 45th Annual General Meeting and Scientific Conference of the Endocrine and Metabolism Society of Nigeria (EMSON) in Abeokuta, Ogun State. The event, themed “Diabetes and Technology,” brought together Nigeria’s leading endocrinologists and healthcare professionals to discuss the role of digital innovations in enhancing diabetes care. The launch of the We Care Diabetes App was a key moment, reinforcing Mega Lifesciences’ dedication to improving healthcare access. Their partnership with EMSON for the symposium further demonstrated their commitment to advancing diabetes care through education and technology.
Speaking at the launch, Mr Maneesh Mehra, managing director of Mega Lifesciences, West Africa, stated, “The We Care Diabetes App is not just a technological innovation—it empowers patients to take control of their health. Through this app, diabetes patients can monitor their condition, track progress, and engage with healthcare professionals from the comfort of their homes. This aligns with our goal to make healthcare accessible to all, particularly in areas where medical facilities are limited.”
Also in attendance was Dr Binu Joy, CEO of Health@Home, the digital division of Mega Lifesciences. Dr Joy highlighted the importance of data-driven, personalised care for patients, saying, “The digital healthcare landscape is evolving rapidly, and with the We Care Diabetes App, our focus is on providing precision and personalised care to each patient. The platform goes beyond diabetes monitoring—it offers patients visibility and autonomy in managing their condition, while fostering a community of care.”
L-R: Dr Akinyele Akinlade, consultant physician/endocrinologist, Department of Medicine, General Hospital Lagos; Professor Michael Olamoyegun, professor of Medicine, Ladoke Akinola University of Technology, consultant endocrinologist, LAUTECH; Professor Olufemi Fasanmade, professor of Medicine, College of Medicine, University of Lagos, consult endocrinologist, LUTH); Dr Ibitrokoemi Korubo, consultant endocrinologist and diabetologist; and Dr Binu Joy, CEO Health @Home, Digital Division, Mega Lifesciences Global.
Binu also emphasised the app’s ability to bridge the communication gap between healthcare providers and patients, stating, “One major challenge for both patients and doctors is the lack of real-time data and communication. The We Care Diabetes App addresses this by enabling continuous interaction, allowing doctors to offer timely interventions based on real-time data.” He reiterated the company’s commitment, saying they aim to provide solutions that tackle healthcare challenges and help patients live healthier, longer lives through digital tools.
The Health@Home CEO further stated that the new diabetes app offers multiple features that enhance diabetes management, such as blood glucose monitoring, which allows patients to log and track their daily readings and gain valuable insights into their health. “It also includes real-time health coaching from certified professionals to guide patients in managing their diabetes more effectively. Additionally, users can store and share their medical records, lab results, and prescriptions with healthcare providers, which improves the efficiency of consultations,” he said.
Mr Amit Singh Raguvanshy, head of the Chronic Care team at Mega Lifesciences, explained that the app was designed to meet the needs of diabetes patients by guiding them through every aspect of managing their condition.
In a country like Nigeria, where access to healthcare can be inconsistent, the We Care Diabetes App offers an innovative solution to many of the challenges faced by diabetes patients. Prof. Michael Olamoyegun, a consultant endocrinologist at Ladoke Akintola University of Technology Teaching Hospital, highlighted the app’s potential to fill critical gaps in diabetes care: “Many patients, especially in remote areas, struggle with late diagnosis and lack of timely treatment. The We Care Diabetes App bridges this gap by equipping patients with the tools to monitor their health and seek professional guidance remotely.”
Olamoyegun further added, “When patients consistently track their health data, doctors can provide more tailored and timely treatment, significantly improving diabetes management outcomes.”
As the world observes World Diabetes Day, Mega Lifesciences, through the We Care Diabetes App, takes a meaningful step towards addressing the campaign’s core theme: access to care. By offering advanced diabetes management tools via a mobile platform, the app empowers patients to take control of their health, wherever they are.
– Tasks Incoming Leadership on Next-Level Development
Pharm. (Elder) Dick Onuigbo, Nigeria’s oldest pharmacist, in the company of Prof. Cyril Usifoh, president, PSN (left), Sir Ifeanyi Atueyi, coordinator of the elders; Hajia Wasilatu Giwa, chairman, PCN, and Pharm. Deji Osinoiki, at the 97th Annual National Conference of the PSN, in Uyo, Akwa Ibom State.Hajia Wasilatu Giwa, chairman, PCN, and Pharm. Deji Osinoiki, at the 97th Annual National Conference of the PSN, in Uyo, Akwa Ibom State.
The atmosphere at the Flairmoore Event Centre in Uyo, Akwa Ibom State, was filled with admiration as the Pharmaceutical Society of Nigeria (PSN) honoured twelve distinguished elder pharmacists, all aged 80 and above, at the closing ceremony of the 97th Annual National Conference.
This special recognition, led by immediate past PSN President Prof. Cyril Usifoh, highlighted the elders’ remarkable contributions to Pharmacy in Nigeria and their enduring commitment to the profession.
A memorable moment during the ceremony was the mention of Pharm. Dick Onuigbo, who will celebrate his 100th birthday in December 2024, and Sir Ifeanyi Atueyi, aged 85, who played a key role in mobilising these elder pharmacists, affectionately termed “the 12 elders.”
Usifoh extended his heartfelt appreciation to Atueyi for facilitating their attendance at the conference, stating that their presence embodied a legacy of service and dedication that has sustained the profession.
Prof. Usifoh expressed his gratitude to all elder pharmacists present, acknowledging their unwavering support throughout his administration and their commitment to attending this historic conference. The recognised elders were: Pharm. Dick Onuigbo, Pharm. Dick Nwoke, Prof. Oleka Udeala, Pharm. Ben Enemmo, Prof. Bona Obiorah, Pharm. Deji Osinoiki, Prof. Philip Olurinola, Pharm. Ugbaga Ugbaga, Pharm. Claudius Aina, Pharm. Jacob Ogundare, Pharm. (Dr) Benjamin Ekpo, and Pharm. (Sir)Ifeanyi Atueyi.
Pharm. Dick Onuigbo, the oldest pharmacist in Nigeria, and Pharm. (Sir) Ifeanyi Atueyi, the coordinator of the elders.
Reflecting on his administration’s achievements, Usifoh underscored efforts to enhance regulatory standards in both veterinary and human pharmaceutical practices, improve pharmacists’ welfare, and secure landmark policy achievements. He noted a recent judicial victory affirming the Pharmacy Council of Nigeria’s right to oversee veterinary drug outlets, which he called “a sound judgment” strengthening the PSN’s regulatory scope.
In the area of public sector pharmacy welfare, Usifoh highlighted the Society’s recent Memorandum of Understanding (MoU) with the Federal Government, which included provisions for improved remuneration, consultancy status for pharmacists in federal institutions, and an increase in retirement age to 65 for general workers and 70 for consultants. He emphasised his administration’s commitment to integrating these reforms into federal budgeting and operations.
Additionally, Usifoh celebrated the Society’s financial stewardship, noting that the PSN headquarters had transitioned to full solar power, resulting in significant cost savings. He assured members that he was leaving the society in a stable financial position, with over ₦180 million in reserves, accrued from conference profits and member contributions.
Encouraging the incoming leadership, Usifoh urged them to continue expanding PSN’s influence, stating, “occupy any vacant seat and lead PSN into a new era of impact.” His remarks received a standing ovation, particularly as he highlighted the contributions of the 12 elder pharmacists, inspiring attendees with their stories of dedication and resilience.
In his response, Sir Ifeanyi Atueyi expressed his gratitude for the recognition, saying, “It has been my privilege to bring together these esteemed colleagues who have given their lives to Pharmacy. Witnessing this honour today is a deeply fulfilling moment for us all.” He added, “Our profession is a calling, and as elder pharmacists, we have the responsibility to guide the next generation, passing on the values that define our work. I thank Prof. Usifoh and the PSN for this recognition.”
The ceremony ended with a unified sense of pride, symbolising the Society’s respect for its elders and dedication to intergenerational strength and continuity within the PSN. The event underscored PSN’s commitment to celebrating its veterans and fostering strong ties across generations.
Morinda lucida Benth, from the Rubiaceae family, is a tropical rainforest tree commonly known as the “Brimstone tree.” In Nigeria, it is called oruwo or ruwo in Yoruba, huka or eze-ogu in Igbo, and njisi in Hausa. It is also known as a “nutrient factory.” In Togo, it is referred to as amake or atak ake.
Constituents
Phytochemical analysis of Morinda lucida extracts has revealed the presence of tannins, alkaloids, steroids, saponins, flavonoids, phenols, and anthraquinones. The plant is also rich in vitamins A, K, and E, along with moderate amounts of proximate compounds such as carbohydrates, protein, fat, fibre, ash, and moisture.
Preparations
Morinda lucida is available in various forms, including the whole plant, leaves, stem bark, and roots. The root bark or leaves can be used fresh, pounded, chopped, or boiled. They can also be prepared as decoctions, infusions, or plasters.
Pharmacological actions and medicinal uses
The presence of anthraquinones, steroids, alkaloids, and tannins in Morinda lucida explains its potential in managing ailments such as constipation, heart conditions, malaria, and diarrhoea. It is one of the four most commonly used plants in traditional medicines for treating fevers.
Plant extracts have been reported to show anti-inflammatory, analgesic, antibacterial, anti-malarial, gastric motility, anti-hepatotoxic, vermicidal, antipyretic, anti-thrombotic, antioxidant, and cardio-protective properties. In simpler terms, it detoxifies and protects the liver, kills intestinal worms, reduces fever, prevents blood clots, combats free radicals, and safeguards heart muscles. Additionally, inhibitory effects on cancer tumours in mice have been reported. The richness of the plant in vitamins A and E, two powerful antioxidants, makes it valuable in managing degenerative diseases such as atherosclerosis.
In Central and West Africa, infusions and decoctions of the root, bark, and leaves are used to treat a range of ailments, including trypanosomiasis, diabetes, insomnia, dysentery, cerebral congestion, stomach ache, ulcers, wounds, abscesses, chancres, microbial infections (including leprosy and gonorrhoea), and worm infestations. In South-West Nigeria, a filtrate of macerated fresh leaves in fresh palm wine is used orally to control blood sugar levels in suspected diabetic patients.
The leaf and stem bark are reported to have anti-spermatogenic properties. Additionally, the leaves are used to treat and improve all forms of infertility in women. Locally, the Brimstone tree is also used to treat irregular menstruation, insomnia, jaundice, and fever during childbirth.
Adverse effects
No known adverse effects have been reported for Morinda lucida, even after acute and sub-acute toxicity studies conducted on Wistar rats.
Economic uses and potentials
The wood of Morinda lucida yields yellow to red dyes. In Nigeria, Gabon, and Congo, it is used to dye textiles and baskets scarlet red and pale green, respectively. The bitter roots are used to flavour food and alcoholic beverages, and in Nigeria, they are popular as chewing sticks. The wood is also useful for making charcoal, construction, mining props, furniture, canoes, poles, and fuelwood. Additionally, the leaves are used for cleaning and scouring. There is great potential in the cultivation, processing, sale, and distribution of Morinda lucida and its products.
References
Adeleye O.O., Ayeni O.J., and Ajamu M.A. (2018). Traditional and Medicinal Uses of Morinda lucida. Journal of Medicinal Plants Studies, 6(2): 249-254.
Medical textiles have transformed healthcare by extending beyond traditional fabric uses. These materials are now vital in creating products that aid in patient care, hygiene, and recovery. Medical textiles combine advanced textile technology with medical science and are found everywhere, from simple bandages to complex artificial organs.
To be effective, medical textiles need to meet strict requirements. They must be flexible, absorbent, non-toxic, and safe for prolonged use. Additionally, they should be strong, biodegradable, and sterile, ensuring they can be used for various treatments without causing harm. As the healthcare industry evolves, so do the demands on medical textiles, with innovations designed to enhance patient comfort, reduce infection risks, and improve the overall quality of care.
Recent breakthroughs, such as smart fabrics and nanotechnology, are playing an increasingly important role in healthcare. These advancements not only improve the efficiency of medical treatments but also contribute to patient well-being, helping doctors monitor and treat conditions more effectively. The use of medical textiles in healthcare has expanded into both implantable and non-implantable products, opening new doors to better care and faster recovery.
Making medical textiles effective
Medical textiles are highly specialised materials that need to meet specific design requirements based on their intended use. Below are some key applications, along with the forms these textiles should take to meet medical needs:
Contact lenses: Made from hydrogel or silicone hydrogel, these should be thin, breathable, and retain moisture, ensuring high oxygen permeability for comfort during extended wear.
Artificial corneas: Constructed from flexible, biocompatible materials like hydrophilic polymers or collagen, providing transparency and mechanical strength for vision restoration.
Artificial kidneys: Hollow fibre membranes, typically made from polyester or polyvinyl alcohol, should have microporous structures to filter blood efficiently during dialysis, while remaining durable and biocompatible.
Artificial lungs: Hollow fibres, usually under one micrometre in pore size, made from materials like PEEK, should effectively facilitate gas exchange, removing carbon dioxide and replacing it with oxygen.
Artificial ligaments: Woven polyester fibres mimic natural ligament movement, providing flexibility and strength, crucial for supporting the body’s range of motion.
Artificial bones: Ultra-high molecular weight polyethylene (UHMWPE) forms rigid, durable structures, ideal for bone replacement, with surface treatments to encourage bone cell growth.
Artificial liver: Devices utilise hollow fibres made from materials like polysulphone, designed to support live liver cells for temporary metabolic support.
Smart medical textiles and nanotechnology
The rise of smart textiles and nanotechnology has created exciting new possibilities in healthcare. Smart textiles are fabrics embedded with sensors that can monitor a patient’s vital signs, such as heart rate or body temperature. This technology allows healthcare professionals to track patients’ health in real-time without the need for invasive procedures.
Nanotechnology, on the other hand, involves using materials at an incredibly small scale—often on the nanometer level—to solve medical challenges. These materials offer properties such as increased strength, flexibility, and responsiveness. Nanofibers, for example, can be integrated into wound dressings to release medication directly to the affected area, promoting faster healing and reducing the risk of infection.
How smart textiles are used
Smart bandages: These high-tech bandages contain sensors that monitor the healing process and can detect infections before they become severe. By keeping a close eye on wounds, smart bandages can ensure that treatment is adjusted quickly, leading to faster recovery times.
Health monitoring clothing: Fabrics with built-in sensors are increasingly being used in everyday clothing to monitor patients’ vital signs. For example, smart shirts and undergarments can track heart rate, blood pressure, and even breathing patterns. This technology is particularly beneficial for heart patients who need continuous monitoring. If abnormalities are detected, healthcare providers are alerted immediately, reducing the risk of serious complications.
Nanofiber dressings: Wound dressings made from nanofibers can release antibiotics or pain medication directly to the injury site, helping wounds heal more quickly and preventing infection. These dressings also allow air to circulate, which is critical for proper wound care.
The future of medical textiles
As research continues, the future of medical textiles holds great promise. Scientists are exploring new materials and technologies to create even more advanced textiles that are lighter, stronger, and more versatile. The goal is to make medical treatments less invasive, more comfortable, and more efficient for both patients and healthcare providers.
From helping the body heal faster to enabling remote health monitoring, medical textiles are becoming an integral part of modern healthcare. As the healthcare sector continues to evolve, so will the role of these innovative fabrics, paving the way for more personalized and effective treatments.
The Nigerian Meteorological Agency has issued a weather forecast indicating the likelihood of dust haze and rain nationwide from Monday to Wednesday.
NiMet’s weather outlook released on Sunday in Abuja envisaged a slight dust haze on Monday with localised visibility of 2 km to 5km in the northern region during the forecast hours.
“In the North Central region, slight dust haze with localised visibility of 2km to 5km is expected during the forecast period.
“In the South, sunny skies in a hazy atmosphere are expected over the inland, with prospects of thunderstorms with slight rains anticipated over parts of Lagos, Akwa Ibom, and Cross River States in the morning.
“Towards the afternoon/evening hours thunderstorms with slight rains are expected over parts of southern Ondo, Ogun, Lagos, Edo, Cross River, Akwa Ibom, Bayelsa, Rivers, and Delta States,” it said.
The agency predicted a slight dust haze on Tuesday with localised visibility of 2km to 5km during the forecast hours in the northern region.
According to NiMet, a slight dust haze with localised visibility of 2km 5km is expected during the forecast period in the North Central region.
It anticipated sunny and hazy skies over the inland and patches of clouds over the coastal states during the forecast period in the southern region.
The agency forecasts slight dust haze with localised visibility of 2km to 5km during the forecast hours in the northern region on Wednesday.
”In the North Central region, slight dust haze with localised visibility of 2km to 5km is expected during the forecast period.
“In the southern region, sunny and hazy skies are anticipated over the Inland while patches of clouds are expected over the coastal States.
” Later in the day, thunderstorms with moderate rains are anticipated over parts of Lagos, Cross River, Rivers, Bayelsa, and Akwa Ibom States,” it said.
NiMet urged the public to take necessary precautions as dust particles are in suspension.
It advised people with asthmatic health conditions and other respiratory issues to be cautious of the present weather conditions.
“Strong winds may precede the rains in areas where thunderstorms are likely to occur, so the public should take adequate precautions.
“Adhere to safety advisories issued by relevant authorities.
“‘Airline operators are advised to get airport-specific weather reports (flight documentation) from NiMet for effective planning in their operations.
“Residents are advised to stay informed through weather updates from NiMet”, it said.
Stakeholders in the health sector have hailed the Federal Government’s free Caesarean Section initiative for pregnant women, describing it as a critical move toward reducing preventable maternal deaths.
The stakeholders commended the programme while speaking with the News Agency of Nigeria on Sunday in Abuja.
NAN reports that the Federal Government unveiled a nationwide free C-Section initiative aimed at reducing Nigeria’s alarming maternal mortality rates.
The Coordinating Minister of Health and Social Welfare, Prof. Muhammad Pate, announced the initiative at the three-day Health Sector-Wide Joint Annual Review which ended on Friday.
According to him, under the initiative, C-sections and essential maternal care would be provided free of charge to eligible women across the country, targeting areas with the highest maternal deaths.
A maternal and reproductive health advocate, Dr Ejike Oji, emphasised the need for a holistic approach to ensure the programme’s success.
“When I conceptualised the Midwifery Service Scheme years ago, I was disheartened by the high maternal mortality rate.
“Nearly 80 per cent of women deliver in rural areas where skilled attendants are scarce, making them vulnerable if complications arise.”
Oji said with free C-sections, women could receive timely surgical intervention without financial strain.
He stressed that public education and community engagement were essential to reach these women before emergencies occurred.
Oji, who is the chairman, Association of the Advancement of Family Planning, stressed the need for an informed healthcare workforce and better infrastructure, particularly in rural Primary Healthcare Centres.
He called for community awareness campaigns to inform women about the availability of free C-sections, as well as the strengthening of referral systems to facilitate timely transfers from rural PHCs to better-equipped facilities.
“This programme will only succeed if the referral system is efficient, linking primary centres to secondary and tertiary facilities,” he noted.
Oji also emphasised the media’s role in raising awareness and mobilising communities.
He added that delivering information to rural areas through accessible media channels would ensure that families understand the availability of free C-sections and seek timely care.
On his part, the Managing Director, Society for Family Health, Dr Omokhudu Idogho, said that the policy was transformative and removed financial barriers.
He, however, said that it was more critical to get women into facilities in the first place through Antenatal Care and community outreach.
According to him, without access to comprehensive ANC, the healthcare system cannot anticipate complications requiring C-sections.
To bridge the gaps, he suggested that healthcare organisations continued working within communities to remove barriers, especially in rural areas.
He highlighted the importance of addressing delays in recognising danger signs, reaching health facilities, and receiving care at facilities as the “three delays” that lead to maternal mortality.
Idogho also pointed out the significance of integrating private healthcare providers into the programme, as a substantial number of Nigerians relied on private healthcare services.
He suggested a voucher system to allow women to access C-sections at private facilities if needed.
“Incorporating the private sector is essential to expand reach.
“If we address both public and private sectors effectively, we can see up to a 70 per cent reduction in maternal mortality, transforming maternal health in Nigeria.”
L-R: Director of Communications, PLPI, Dr Fyneray Mbata; Editor of Pharmanews, Mr Patrick Iwelunmor; Director General/CEO, PLPI, Dr Nathan Obasi; and Director, Mobilisation/Finance, PLPI, Mr Chukwuma Ugwuegbu, at the event.
Publisher and Managing Director of Pharmanews, Pharm. (Sir) Ifeanyi Atueyi, has been conferred with the Professional Leadership Practitioners’ Institute Award, in recognition of his transformational leadership initiatives in the area of health/wellness innovation.
The award ceremony, which took place on Thursday 7 November, 2024 at the CET Hall, Faculty of Education, University of Lagos, Yaba, was part of activities marking the 2024 Annual Conference and Fellowship Investiture of the institute with the theme, “Leadership and Leadership Development in a Digitally Evolving Contemporary Society.”
Receiving the award on behalf of Pharm. (Sir) Ifeanyi Atueyi, Editor of Pharmanews, Mr Patrick Iwelunmor, thanked the institute for finding his boss worthy of the recognition, adding that the foremost pharmacist and octogenarian is one Nigerian that has remained consistent in his pursuit of excellence through innovative leadership.
Earlier in his welcome address, Director General and CEO of PLPI, Dr Nathan Obasi, said the institute has made progress since its inception and will continue to propagate professionalism in leadership at all levels.
“The journey of the institute started in 2016 and has never been so eventful as it has been this outgoing year. We have imagined and reimagined the concept of leadership as it evolves over the years. Today, leadership is not just for people who hold top management positions and functions.
“Everyone can lead from where they are. Leadership is now democratised. It is now the provision of vision and influence on others to realise set goals and objectives through non-coercive means. At PLPI, we aim at drawing forth a person’s highest qualities by influence more than coercion,” he said.
Guest Speaker, Professor J.K. Ayantayo of the Faculty of Arts, University of Ibadan, called on leaders to keep themselves abreast of the times by keying into the digital revolution in order to remain informed, relevant and innovative, adding that the world is moving at a digitally rapid pace. For leaders to excel and make a difference, he added that they must be willing to embrace new realities that abound in the digital space.
Pharm. Tanko Ayuba, the newly elected PSN president, presenting a commendation plaque to the immediate past president, Prof. Cyril Usifoh
The newly elected President of the Pharmaceutical Society of Nigeria (PSN), Pharm. Ibrahim Tanko Ayuba, has pledged to make good his campaign promises to pharmacists, as he appreciated all that made his emergence a possibility.
Ayuba made this statement in his first address to pharmacists after he was declared winner of the very competitive presidential election, that took place 97th Annual National Conference of PSN, in Uyo, Akwa Ibom State.
He also declared his administration an all- inclusive one, that will ensure no pharmacist is oppressed or discriminated against. He said unity among pharmacists will be a major driver of his tenure.
He said, “During the run-up to the elections, we promised to carry out a number of programmes, projects, and advocacy initiatives that will not only sustain the remarkable strides achieved by my predecessors, but will also enhance the value and visibility of the Nigerian pharmacist within the healthcare delivery space.
“You can hold me accountable for these promises,” he avowed.
The new helms man of PSN, who termed his government as ‘Our Presidency”, expressed his appreciation to his supporters who gave him their mandate, assuring them of his capacity to deliver a progressive PSN in the shortest possible period.
He acknowledge the magnitude of the task ahead of him, especially with myriads of threats to the profession in Nigeria, He however, assured them of what he possesses in terms of capacity, competence, and connections that will ensure the years of relegating pharmacists and Pharmacy profession to the background are over.
He further buttressed on his agenda for the Society thus, ”To achieve, and indeed, exceed our goals and campaign promises, unity within our team and the Society remains a key driver that we must keep in focus. We are a PHARMILY.
“This is why I have called this our presidency. It is our presidency because the PSN belongs to all of us!
“It is our presidency because we shall be building and rebuilding bridges, and also mending fences.
“It is our presidency because there are no victors or losers! With me, Pharmacy wins all the time. It is our presidency because I shall run an all-inclusive government, where no Nigerian pharmacist shall be oppressed or discriminated against.
“It is our presidency because I shall be your servant leader. It is our presidency because we shall continuously subject ourselves to your scrutiny for accountability, integrity, and performance.”
The number-one pharmacist in Nigeria expressed his appreciation to the Immediate Past President, Pharm. (Prof.) Cyril Odianose Usifoh, for the provision of quality leadership over the years, and creation of a level playing ground in the last three years for all actors to express their aspirations.
– As Okeri, Isyaku, Ezenekwe, Ajibade, Ndukwu won other positions
Pharm. Tanko Ayuba, the newly elected PSN president, presenting a commendation plaque to the immediate past president, Prof. Cyril Usifoh
The Pharmaceutical Society of Nigeria (PSN) has elected Pharm. Ibrahim Tanko Ayuba as its new president.
Ayuba emerged winner at the elections held at the Ibom Hall, Uyo, Akwa Ibom State, Venue of the 97th Annual National Conference of the PSN in Akwa Ibom State.
Declaring the results at the closing banquet at the recent 97th PSN conference in Akwa Ibom State early hours of Saturday, 9 Nov., 2024 at Flairmoore Event Centre, Uyo, Akwa Ibom State, the Electoral Committee Chairman, Pharm. Babashehu Ahmed, declared Ayuba returned and elected, having garnered the maximum valid votes in the elections.
The new set of PSN National Executives being sworn in after the declaration of the results
The new set of PSN National Executives being sworn in after the declaration of the results
According to Ahmed, who is the current registrar, Pharmacists Council of Nigeria (PCN), Ayuba edged out the two other contenders, polling a total of 852 votes, while Dr Joel Adagadzu came second with 718, while Pharm. (Mrs) Ejiro Foyibo polled 144 votes to secure third position.
The election umpire added that Pharm. (Prof.) Henry Okeri won Deputy National President South with 630 votes, defeating Pharm. Akpabio Akaowa who polled 539 votes and Pharm. Victoria Ukwu who had 533 votes.
Similarly, Pharm. Aisha Tukur Isyaku, who contested unopposed has been elected Deputy National President North.
Pharm. Lizette Ezenekwe, emerged the National Publicity Secretary, with 922 votes to beat his opponents Pharm. Charles Ronari who polled 691, and Pharm.(Dr) Ugochinyere Ogudu with 131 votes.
For the unofficial members, Pharm. Abiodun Ajibade and Pharm. Felix Ndukwu, cleared the two available slots with 788 votes and 697 votes respectively.
Highlights of the event were the presentation of awards of excellence to exceptional individuals in recognition of their significant contributions to the pharmaceutical industry and their support for the success of the PSN conference in Akwa Ibom.
In my hometown, if you visit someone and meet him eating, it is believed that you are thinking well of that person. Normally, he will invite you to join him in eating, even though there was no provision for you. Whether you accept the invitation or not is not the issue. The important thing is that you arrived at the right time to meet the food. Do you sometimes wonder how you get a place at the right time or the wrong time?
Do you know that someone can walk into an accident and become unfortunate while another person can walk away from a scene just before an accident? It could be a difference of minutes. Was that person who left the scene just before the accident a smarter or more intelligent person? This is a principle of life which applies generally.
The wisest king, Solomon, deeply meditated on this principle of life and made a profound statement as recorded in Ecclesiastes chapter 9:11. “I have seen something else under the sun. The race is not to the swift or the battle to the strong, nor does food come to the wise or wealth to the brilliant or favour to the learned. But time and chance happen to them all.”
There is no doubt that there is an unseen Guide who directs people. All you need to do is to listen carefully and do as directed. You may be directed to do something that seems stupid in your own eyes, but that is the right thing to do. Do it. At that moment, do not resort to your natural intelligence or wisdom. Just behave like a child and do what you are told to do.
Many of us make good plans for business, sometimes hiring the best consultants. But no matter how good a plan may be, only God can make it work. How the business plan will turn out is clearly beyond what any consultant can forecast. That is why Proverbs 16:3 says, “Commit to the Lord whatever you do, and your plans will succeed.” I think that whatever plan we make is like a sketch or a draft which we have to submit to God for the finished work. He is pleased with someone who realises that only Him can bring our design to perfection. Proverbs 16:9 says, “In his heart a man plans his course, but the Lord determines his steps.” God is responsible for the outcome of your plans because He alone is omniscient.
In 1979, when I started Pharmanews, I was desperate to secure advert support from the pharmaceutical companies to enable me take off. Some friends and colleagues promised support later, while a few gave me the initial adverts. But no company was willing to pay until the first edition was published. However, I needed the money to publish this maiden edition to convince the company to support me.
I had a vision, alright, but there was no money. One afternoon, I remembered I had seen the signboard of a pharmaceutical company at Ilupeju, but I had not been there before and did not know anybody there. But God directed my steps to that place. I signed the visitor’s slip which was sent in to the managing director. I was asked to come in. This German warmly welcomed me as if he had met me before and asked what he could do for me.
I quickly shared my vision of a monthly 12-page A3 size pharmaceutical newspaper to be distributed to pharmacists and doctors all over the country and asked for advert to support it. I showed him my mock-up with spaces for advert. He listened carefully and caught the vision immediately. He asked, “How will you send it to pharmacists and doctors?” “I will fold the copies with brown paper and post them.” No!! he replied. “Use very good white paper and I will advertise on it also.”
He received the mock-up and immediately booked some premium spaces and asked me to send him the bill for May to December 1979 to be paid in advance. Then he would retain the spaces and pay upfront every January from 1980 until he decided to stop. With a cheque for the next eight months in my hand, the business of Pharmanews took off.
I continue to give glory to God for directing my steps to a person I had never met before to launch my business when I could not find a relation or a friend to do so for me. I believe that if God gives a commission, He makes the provision.
He is always seeking the person to commission and equip. The person may not be the smartest or the most capable, but time and chance happen to everything. He looks at a man’s heart while people look at the physical features. He knows the motives of people and weighs them as precious gold is weighed on a scale.
– As Pharmanews Presents Plaque, Cash Prize to him
Jumbo Nengi, 2024 Pharmanews PANSite of the year award winner, receiving his Plaque from Pharm. (Sir) Ifeanyi Atueyi, managing director, Pharmanews Limited.
The 97th Annual National Conference of the Pharmaceutical Society of Nigeria (PSN) in Uyo, Akwa Ibom State, became a memorable occasion for Jumbo Nengi, a final year Pharmacy student of the University of Uyo’s Faculty of Pharmacy, who recently graduated, as he received the prestigious Pharmanews PANSite of the Year Award.
The Award Plaque was presented to him by the Octogenarian Publisher of Pharmanews, Pharm. (Sir) Ifeanyi Atueyi, who is a longstanding figure in Nigerian Pharmacy.
Nengi, who is fondly referred to as “Uncle Nengi” by his peers, shared that his journey to this moment was marked by years of dedication, strategy, and passion. “This was always one of the awards I aimed to win,” he said. “I discovered it in my 200 level and began preparing then, getting involved in public health and taking on roles that allowed me to make a difference.”
Reflecting on his time at the university, Nengi recalled his leadership roles, especially within the Anti-Drug Abuse Programme (ADMAP) at UNIUYO. “Throughout my university years, I held prominent positions that enabled me to advocate against drug misuse, which became a cornerstone of this mission,” he said, adding that his experiences in public health and as a leader within the Pharmaceutical Association of Nigerian Students (PANS) were instrumental in his journey.
Despite his years of preparation, Nengi admitted he was taken aback by the overwhelming support he received from students nationwide. “I didn’t expect this level of backing from PANSites across Nigeria,” he expressed. “Winning this award, especially with someone else from my university also in the race, truly touched me.”
In his response, Sir Atueyi commended him and all previous recipients of the PANSite of the Year Award, which he described as a recognition of excellence, resilience, and service among pharmacy students across Nigeria.
Speaking at the event, Atueyi stated, “The PANSite of the Year Award was born out of a desire to recognise the exceptional talents, leadership, and dedication among young pharmacy students across this nation. This award is not merely a plaque or a title; it represents an acknowledgment of the tireless work, selfless service, and enduring commitment of each recipient towards advancing the noble goals of Pharmacy and healthcare in Nigeria.”
He continued, acknowledging the achievements of past winners and their contributions to the profession. “Over the past five years, we have seen outstanding young individuals who have inspired us with their ambition, their willingness to serve, and their passion for making a difference. Each awardee, in their unique way, has embodied the principles that we hold dear in this profession,” he said.
Listing the past winners such as Yusuf Hassan Wada from Usmanu Danfodiyo University in Sokoto; Izukanne Emembolu from Nnamdi Azikwe University; Martin Chukwunonso Nwofia from Chukwuemeka Odumegwu-Ojukwu University; Jennifer Ekuma from the University of Uyo; and Ahmed Olasunkanmi Ajilaran from the University of Lagos, Atueyi welcomed Nengi into the distinguished group of Pharmanews Ambassadors.
“Today, we welcome a new member to this esteemed family: Jumbo Nengi. His journey, his commitment, and his achievements are a testament to the spirit that this award seeks to celebrate. His planning, dedication, and resilience exemplify what it means to be a true PANSite of the Year, and we are confident that he will continue to make a positive impact in our profession.”
Sir Atueyi concluded by urging pharmacy students and young pharmacists to strive for excellence, describing pharmacy as “a calling, one that requires diligence, compassion, and a commitment to lifelong learning
While speaking, Mrs Temitope Obayendo, online editor, Pharmanews, who joined virtually, said the event was not meant to celebrate just Nengi’s accomplishments, but the spirit of resilience and determination embodied by all awardees, saying Nengi’s journey serves as an inspiring reminder of what can be achieved through focused ambition and a heart for service.
She hinted on the ongoing nomination for the Young Pharmacist of the Year 2024, saying it is another opportunity for young pharmacists committed to healthcare innovations to emerge among contestants for the online poll, among whom a winner will eventually emerge. She thus urged pharmacists and pharmacy students, who are yet to make their nominations through the Pharmanewsonline.com to do so in time, as the exercise closes on 13 November, 2024.
Jumbo Nengi, 2024 Pharmanews PANSite of the year award winner, receiving his Plaque from Pharm. (Sir) Ifeanyi Atueyi, managing director, Pharmanews Limited.
Jumbo Nengi, 2024 Pharmanews PANSite of the year award winner.
In response to the recent surge in Mpox cases across Africa, the Access and Allocation Mechanism has allocated a batch of 899,000 vaccine doses to nine African countries severely impacted by the outbreak.
This joint initiative, launched by the Africa Centre for Disease Control and Prevention (Africa CDC), the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance, UNICEF, and the World Health Organisation (WHO), aims to curb the spread of Mpox by prioritising regions with the highest transmission rates.
According to a joint press release from these agencies, this collaboration seeks to ensure that the limited vaccine doses are used fairly and effectively, based on epidemiological data of each country.
The nine countries set to receive vaccine doses include the Central African Republic, Côte d’Ivoire, the Democratic Republic of the Congo (DRC), Kenya, Liberia, Nigeria, Rwanda, South Africa, and Uganda.
The DRC, which remains the epicentre of the outbreak, is expected to receive 85 percent of the allocation, as it has reported four out of every five confirmed cases in Africa this year. “The scale of the outbreak in the DRC underscores the urgency of focused vaccine distribution in the region,” the release highlighted, noting that these countries’ allocations aim to address the worst-hit areas.
These doses have been secured through donations from Canada, Gavi, the European Union (EU), and the United States, with contributions coming from EU member states, including Austria, Belgium, Croatia, France, Germany, and Spain, as well as from the United States and Canada. In light of the rapid spread of the clade Ib strain of Mpox, the vaccination programme marks a coordinated approach to address the outbreak, which has affected 19 African countries, many experiencing cases for the first time.
Declared a public health emergency of international concern by WHO and a public health emergency of continental security by Africa CDC in August, the Mpox outbreak has led to more than 38,000 suspected cases and over 1,000 deaths in the DRC alone this year. Africa CDC affirmed that vaccination is a key component of the broader Mpox response strategy, which also includes testing, clinical care, infection prevention, and community engagement.
According to the statement, the phased vaccination strategy targets three stages wherein Phase 1 aims to vaccinate approximately 1.4 million individuals at risk by the end of 2024, using 2.8 million doses of the MVA-BN vaccine.
“By focusing initially on those at greatest risk of exposure, we aim to interrupt transmission in the areas with the highest case counts.”
“Subsequent phases of the rollout will expand to cover additional high-risk populations as more doses become available. Phase 2 focuses on protecting individuals at risk of severe disease, including vulnerable groups like people living with HIV, internally displaced persons, and refugees in affected regions. Phase 3 aims to build population immunity as a preventive measure against future outbreaks, establishing long-term protection in communities. As doses increase, we will prioritise protection for high-risk populations to support longer-term outbreak control.” the statement reads.
The National Primary Health Care Development Agency says it has unveiled a new comprehensive funding model and enhanced oversight mechanisms to revitalise Primary Health Care Centres across Nigeria.
Its Executive Director, Dr Muyi Aina, disclosed this during the inauguration of the Basic Health Care Provision Fund held on Thursday in Abuja.
Aina said the move was aimed at evaluating progress across the health sector, focusing primarily on the effectiveness of the Sector-Wide Approach (SWAp).
The News Agency of Nigeria reports that Joint Annual Review serves as a vital platform for driving the Sector Wide Approach in the country.
It unites key stakeholders to assess progress, address challenges, and pinpoint opportunities for improvement.
It also reflects on achievements, openly discussing challenges and identifying areas for improvement, creating a constructive space for aligning on what matters most: improving health outcomes for all Nigerians.
Aina said BHCPF reforms are equally aimed at addressing long-standing issues of inadequate funding, mismanagement and inefficiency that have plagued Nigeria’s PHC system.
He stressed that the new reforms focus on improving access to healthcare services, ensuring the effective use of resources and increasing accountability at the local government level.
According to him, the BHCPF reforms introduce a revamped funding structure that prioritises direct allocations to PHCs, with strict financial oversight aimed at curbing waste and corruption.
“This new funding model will ensure that resources are allocated directly to the PHCs based on performance, patient outcomes and facility requirements.
“For the first time, local governments will have a significant role in the allocation and monitoring of these funds, which will make sure that the resources are spent where they are most needed,” he said.
According to him, the BHCPF 2.0 initiative is expected to address the gaps in the delivery of essential health services, including maternal and child health, immunisation and the treatment of common diseases such as malaria and tuberculosis.
He said that the new model also focuses on the integration of digital technologies for monitoring health services and strengthening data collection, reporting and transparency.
“A key aspect of the reforms is the establishment of an independent oversight committee that will monitor the proper utilisation of the funds at the grassroots level.
“This will ensure that financial and operational accountability is upheld and that the PHCs meet the standards required to deliver quality healthcare.
“The unveiling of the BHCPF 2.0 reforms is part of the ongoing efforts by the Nigerian government to boost the effectiveness of its healthcare system and improve the lives of millions of Nigerians in underserved communities.
“The initiative will also enable greater public and private sector collaboration in improving healthcare infrastructure and services,” he said.
Similarly, Dr Bolanle Olusola-Faleye, Chief of Party, USAID Local Health System Sustainability Project (LHSS), said the success of the initiative would depend on its effective implementation at the local level.
Olusola-Faleye said if local communities are fully involved and there is robust monitoring, the funding model could set the stage for transforming Nigeria’s healthcare delivery system.
“The NPHCDA has committed to ongoing engagement with state and local government authorities to ensure the reforms’ seamless rollout.
“In addition, it highlights that continuous training for healthcare workers will be essential to maximise the impact of the BHCPF 2.0 reforms on patient care,” she said.
She said that Nigeria hopes to make significant strides towards achieving Universal Health Coverage (UHC) and improving the overall health outcome of its population, particularly those in rural and underserved areas.
NAN reports that several local and international stakeholders, including donors and civil society organisations, were present at the inauguration, as some stressed the importance of community engagement in the anticipated success of the reforms.
To address some of the lingering challenges bedeviling healthcare in the country, eminent pharmacists and stakeholders at the 97th annual Pharmaceutical Society of Nigeria (PSN) conference in Uyo have urged Nigerian pharmacists to adopt a value-based approach to healthcare, especially in chronic diseases management and preventive care.
Speaking during the first plenary session at the conference, chaired by Hajia Wosilatu Giwa, PCN chairman, which featured impactful contributions from Pharm. (Dr) Teresa Pounds, chairman, West African Society of Parenteral and Enteral Nutrition (WASPEN); Pharm. Wale Oladigbolu, immediate past national chairman, ACPN, and Pharm. (Mrs) Abimbola Adebakin, CEO, Advantage Health Africa, the speakers stressed on the urgent need for a transformative shift in pharmacy practice across Nigeria.
Pharm. Wale Oladigbolu, immediate past chairman, ACPN, and Pharm. (Mrs) Abimbola Adebakin, CEO2, Advantage Health Africa, at the first plenary session of the 97th PSN national conference in Uyo, Akwa Ibom State.
Setting the tone, Giwa highlighted the power of digital innovation to reshape Nigeria’s healthcare landscape, particularly by harnessing tools like electronic health records, telemedicine, and artificial intelligence.
She noted that these technologies could improve healthcare access and efficiency, especially in underserved communities, and called on pharmacists to engage with these advancements. “Digital transformation can drive operational efficiency, lower costs, and boost economic growth, ultimately creating a healthier and more prosperous society,” she stated.
Dr Pounds, as the lead speaker, introduced a comprehensive model for value-based care, advocating for a departure from the traditional fee-for-service approach in favour of a system focused on patient outcomes.
Pounds further outlined how value-based care could allow pharmacists, especially in community settings, to provide medication therapy management, personalised wellness consultations, and patient-centred care, ultimately reducing costs while enhancing patient satisfaction. She described the Management Service Organisation (MSO) model, which allocates administrative functions separately from clinical services, enabling pharmacists to dedicate more time to direct patient care.
Speaking further, Pounds highlighted the success of a pilot programme involving pharmacists equipped with Trust Rx technology, a system that enables patient assessments and continuous health monitoring, particularly for managing chronic conditions such as hypertension and diabetes. She encouraged Nigerian pharmacists to consider such value-based models to drive healthcare improvement across the country.
In his own speech, Pharm. Wale Oladigbolu underscored the unique position of community pharmacies in Nigeria, where over 70 percent of citizens access healthcare through the private sector, arguing that community pharmacies have the potential to bridge gaps left by under-resourced primary healthcare facilities, particularly in terms of access and affordability.
He cited recent policy advances, such as the federal endorsement of pharmacy-administered vaccination services, which have supported community pharmacies in delivering essential health services.
Oladigbolu emphasised that pharmacists must transition from mere dispensers to proactive healthcare providers, equipped with new skills in areas like point-of-care testing and chronic disease management. “This transformation will not only benefit patients but also help pharmacists to progress in their careers through continuous upskilling and stakeholder engagement,” he noted.
In her contribution, Pharm. Abimbola Adebakin, urged pharmacists to embrace their roles as influential healthcare providers, likening them to “princes” in the sector. She challenged pharmacists to recognise their unique advantage of direct patient access and use it as an opportunity to offer personalised, value-based care.
Adebakin cited the growing trend of social media as an untapped platform for pharmacists to share valuable health insights and connect with broader audiences, particularly on chronic diseases management.
“We must move beyond competing on price alone,” Adebakin advised, stressing the potential for pharmacists to introduce subscription models for ongoing care and develop deeper, long-lasting relationships with their patients. Her message to fellow pharmacists was clear: “Tell yourself, I am valuable,” she concluded, urging them to take ownership of their role as essential healthcare influencers in Nigeria.
The speakers, unanimously called for collective action among Nigerian pharmacists to adopt value-based care practices, digital integration, and continuous professional development, aimed at delivering quality care to communities and meeting the nation’s rising healthcare needs.
Hajia Wosilatu Giwa, chairman, PCN, and Pharm. (Alh) Yaro Budah, former president, PSN, with Seagreen Pharma staff during the unveiling.
Seagreen Pharmaceuticals, a sister company to Greenlife Pharmaceuticals, has officially reintroduced Amino Pep Forte, the popular amino acid and multivitamin supplement, at the 97th Annual National Conference of the Pharmaceutical Society of Nigeria (PSN) in Uyo, Akwa Ibom State.
The relaunch, held during the first plenary session of the PSN event, marks Seagreen’s strategic commitment to expanding access to essential health supplements in Nigeria.
Speaking during the unveiling, Mrs Evelyn Okorie, marketing manager for Seagreen Pharmaceuticals, shared her enthusiasm for re-establishing Amino Pep Forte in the Nigerian market. She highlighted the product’s enriched formulation, which combines ten essential amino acids, multivitamins, and zinc. It is designed to bolster immune function, support post-surgical recovery, aid in growth, and promote general wellness across age groups.
“Amino Pep Forte is truly a product for everyone, mama, papa, and pikin,” Okorie remarked, describing the supplement’s versatility in supporting immune health, cell regeneration, and faster recovery. “With amino acids critical for protein synthesis and zinc aiding in wound healing and reducing oxidative stress, Amino Pep Forte addresses a range of health needs, including chronic conditions like diabetes and hypertension.”
Okorie reassured PSN members that Seagreen Pharmaceuticals is committed to overcoming past distribution challenges to ensure Amino Pep Forte is available nationwide. “Seagreen is dedicated to maintaining the highest standards of quality and ensuring Amino Pep Forte becomes the primary choice for amino acid and multivitamin supplementation in Nigeria,” she added.
Adding a significant endorsement, the Chairman of the Pharmacy Council of Nigeria (PCN), Pharm. (Hajia) Wosilatu Giwa, praised the product’s return and commended Seagreen Pharmaceuticals for its dedication to accessible, high-quality healthcare solutions.
“Today, it is my pleasure to reintroduce Amino Pep Forte, a brand trusted by Nigerian households and healthcare professionals alike,” Hajia Giwa stated. “Although it may have left the market temporarily, its legacy of quality and reliability remains strong. With Seagreen at the helm, Amino Pep Forte has not only been rebranded and repackaged but is now supported by a company committed to addressing the health needs of Nigerians.”
Representing the PSN’s vision, Giwa emphasised that the organisation has always supported the promotion of pharmaceuticals that benefit public health, adding that Amino Pep Forte aligns with that mission. “I am confident that Seagreen’s dedication will ensure Amino Pep Forte reaches more homes, clinics, and pharmacies across Nigeria, contributing to a healthier population,” she said.
To mark the relaunch, Giwa invited past and present PSN leaders to join in the product unveiling, with the crowd enthusiastically chanting, “Amino Pep 10 over 10,” celebrating its comprehensive amino acid profile and renewed place in the Nigerian market.
Mr Wasiu Adelodun, national sales manager for Seagreen, also spoke on the relaunch, affirming that Amino Pep Forte is poised to reclaim its status as a trusted supplement. “With this reintroduction, Amino Pep Forte will once again provide the essential nutrients that support immunity, recovery, and overall health for Nigerians of all ages,” Adelodun stated.
– As Over 5000 Pharmacists Set to Elect Usifoh’s Successor, Others
Campaign banners of the three presidential candidates on display at the conference.
The long awaited elections for the next president of the Pharmaceutical Society of Nigeria (PSN), Publicity Secretary, and unofficial members will happen on Friday, 8 November, 2024.
As of Thursday afternoon, 7 November, the Ibom Hall, venue of the ongoing 97th Annual Conference of the PSN was already bubbling.
Other 5,000 pharmacists are participating in the conference. And majority of them, if not all, are expected to vote on Friday.
A cross- section of dignitaries during the unveiling of DUOSTAM at the opening ceremony of the 97th PSN Conference in Uyo, Akwa Ibom State.
As a means of offering effective relief for Benign Prostatic hyperplasia (BPH) patients, PharmacyPlus Limited has introduced to the Nigerian market, DUOSTAM, a dual-action drug that combines Tamsulosin (0.4mg) and Dutasteride (0.5mg), at the opening ceremony of the 97th annual Pharmaceutical Society of Nigeria (PSN) conference in Uyo.
The product, designed to manage BPH symptoms and delay surgical intervention, was launched with endorsements from medical experts and industry leaders at the event.
Leading the launch, Prof Ikenna Nnabugwu, a consultant urologist from the University of Nigeria Teaching Hospital, Enugu, emphasised DUOSTAM’s clinical relevance in managing prostate enlargement, a common condition affecting men as they age.
A cross-section of dignitaries displaying the unveiled DUOSTAM at the opening ceremony of the 97th PSN Conference in Uyo, Akwa Ibom State.
“Benign prostatic hyperplasia is a natural part of aging, but it can cause significant discomfort by obstructing urinary flow. DUOSTAM offers a safe and effective approach to alleviate these symptoms, delay the need for surgery, and improve quality of life,” Prof. Nnabugwu stated.
The drug’s formulation, which includes an alpha-1 blocker and a 5-alpha reductase inhibitor, targets BPH symptoms such as bladder outlet obstruction, urinary retention, and discomfort. “DUOSTAM merges Tamsulosin and Dutasteride to provide a comprehensive approach to treating BPH, offering a solution that slows disease progression and reduces the need for surgical intervention,” he explained.
Addressing misconceptions surrounding BPH, the university don pointed out that many Nigerians confuse “prostate” with “prostrate” and mistakenly believe it signals illness. “The prostate is a vital organ that supports fertility, and benign enlargement is a common aspect of aging. DUOSTAM offers a clinically validated, non-surgical solution for managing these symptoms,” he added.
Pharm. Iyke Aneke, head of marketing at PharmacyPlus, spoke on the company’s mission to improve health outcomes in Nigeria. He highlighted that DUOSTAM was introduced to bring succor to patients with BPH, combining availability and affordability.
“DUOSTAM fills a critical need by providing a medically approved treatment for BPH symptoms,” Aneke explained, adding that its development was supported by extensive research to ensure effectiveness across healthcare settings.
PSN President, Prof. Cyril Usifoh, praised the launch, commending PharmacyPlus’s commitment to healthcare advancements in Nigeria. He affirmed that the introduction of DUOSTAM aligns with PSN’s vision of accessible, evidence-based treatments. “We hope this will be a vital resource for pharmacists and patients nationwide,” Usifoh remarked.
The event concluded with a formal unveiling of DUOSTAM, led by Dr Teresa Pounds and Pharm. Yaro Budah, amidst applause from attendees, signifying PharmacyPlus’s ongoing contribution to healthcare innovation in Nigeria.
Pharmacoeconomics has been identified as one of the veritable fields that will enhance the availability of medicines and other necessities in the Nigerian health sector, which will in turn boost the economy of the country.
Speakers at one of the plenary sessions of the ongoing 97th Annual National Conference of the Pharmaceutical Society of Nigeria (PSN) said on Wednesday that pharmacoeconomics will help to provide alternative treatment plans that are cheaper and more effective for diseases.
The theme of the session is, “Pharmacoeconomics and Global Partnerships to Facilitate Medicines and Healthcare Sundries Availability”.
A cross-section of participants at the plenary session.
In his address at the session, which was chaired by PSN former President, Pharm. Azubuike Okwor, the lead speaker, Dr Emmanuel Omehe said pharmacoeconomics compares the cost and effect of pharma products and services, adding that it is a field that helps policy makers and healthcare providers to make the right decision.
He pointed out that pharmacoeconomics has a big role to play in medicines production, as it helps in assessing financial burden of a new medicines therapy on a healthcare system, adding that the field helps in price regulation as well in identifying essential medicines. He noted that pharmacoeconomics helps in the cost of research & development as well as innovation.
Dr Omehe averred that there is urgent need for global partnership by players in Nigeria’s health sector, saying global partnership will enable players to compare price and effect.
Also speaking at the session, another speaker, a Professor at the Department of Clinical Pharmacy, Faculty of Pharmacy, University of Benin, Tony Waka Udezi explained that pharmacoeconomics studies the economic implications of pharmaceutical products and their value in healthcare. He pointed out that pharmacoeconomics is important to medicine availability, as it helps to improve decision making for resource allocation, assesses cost effectiveness of treatments, affordability and optimal use of medicines.
While highlighting the roles of pharmacoeconomics to medicines and healthcare sundries availability, Prof. Udezi stated that the field helps in Cost Benefit Analysis by comparing costs of healthcare interventions versus outcomes. He added that pharmacoeconomics helps in Budget Impact Analysis, as it helps to understand the economic impact of new medicines on healthcare budgets, adding that pharmacoeconomics ensures that medicines and devices prove additional beneficial outcomes for every penny.
While stating the importance of global partnership, the professor harps on the need for collaboration, which, according to him, encourages sharing of resources and knowledge. Other importance of global partnership, according to the professor, include investment that mobilises funding for research and infrastructure; innovation that drives development of affordable treatments, as well as better disease surveillance and response.
Also speaking at the session, wife of the PSN president, (Mrs) Stella F. Usifoh, also a professor at Faculty of Pharmacy, University of Benin, averred that there is urgent need for pharmacoeconomics in Nigeria, so as to enhance availability of medicines and other necessities in the Nigeria healthcare system.
According to her, pharmacoeconomics will provide an assessment of ADR’s, – efficient pharmacovigilance and reducing negative consequences, provides broad insight into a drug or disease’s medical and financial implications, helps in optimising budget utilisation for best possible treatments without heavy cost-related burden on the patients.
She added that pharmacoeconomics provides alternative treatment plans that are cheaper and more effective for diseases, as newer drugs could be more cost effective and therapeutically efficient than the overused older drugs; enhance good prescription and also enhance effective formulary management by aiding the decision-making process of policies by Pharmacy and Therapeutics.
Meanwhile, according to Prof. Usifoh, there are many barriers to pharmacoeconomics which include absence of a national body to govern pharmacoeconomics, inability to make mindful decision, lack of belief in the importance of pharmacoeconomics, lack of funding to conduct pharmacoeconomics evaluations, as well as lack of data among others. She however disclosed that there are guidelines that can help to achieve pharmacoeconomics.
“Integrating pharmacoeconomics with global partnerships can significantly improve medicine availability and quality of healthcare. We should encourage all stakeholders to collaborate for better healthcare outcomes. Governments needs to Invest in healthcare infrastructure and adopt pharmacoeconomics principles”, Prof. Usifoh said.
She also called on the private sector to engage in public-private partnerships and adopt affordable pricing strategies; even as she urged global organisations to continue to provide technical assistance and funding support.
...As Shalina Celebrates 40 Years of Commitment to Quality Healthcare
Prof. Cyril Usifoh, president, PSN, and Pharm. (Chief) Emeka Adimoha, pharma director and regulatory head, Shalina Healthcare, flanked by Pharm. Gafar Madehin, national secretary, PSN and Mr Chiuba Nwaosu, marketing manager, Shalina Healthcare, after the signing of the MOU.
In a significant partnership aimed at enhancing access to quality pain relief, the Pharmaceutical Society of Nigeria (PSN) has signed a Memorandum of Understanding (MOU) with Shalina Healthcare to endorse IBUCAP capsule, a flagship pain relief medication.
The endorsement was formalised at the opening ceremony of the 97th PSN Annual National Conference, held at Ibom Hall, Uyo.
Speaking on behalf of Shalina Healthcare, Pharm. Chief Emeka Adimoha, pharma director and regulatory head, expressed gratitude for the endorsement, highlighting IBUCAP’s effectiveness and longevity as a trusted painkiller.
“This MOU signifies PSN’s endorsement of IBUCAP as a high-quality painkiller,” he stated. “For over 20 years, IBUCAP capsule has proven its value in Nigeria, and with PSN’s support, we look forward to continuing to provide Nigerians with reliable and affordable medication options.” Adimoha noted that Shalina’s ongoing expansion efforts aim to increase production capacity and foster greater local impact.
A cross-section of PSN and Shalina’s teams after the signing of the MOU
Reflecting on the company’s milestone of 40 years in the healthcare sector, Adimoha added, “This endorsement is particularly meaningful as we celebrate four decades of commitment at Shalina and twenty years of trust in IBUCAP capsule. I feel both elated and motivated to continue our work in supporting Nigeria’s healthcare needs.”
In response to the MOU, PSN President Prof. Cyril Usifoh commended Shalina Healthcare’s commitment to quality, saying the PSN’s endorsement of IBUCAP capsule is not just a recognition of its efficacy as a triple-action pain reliever but also a testament to Shalina’s dedication to making quality drugs accessible to Nigerians.
Prof. Usifoh emphasised PSN’s mission to endorse products that meet rigorous standards and bring value to the healthcare sector. “With this partnership, we are aligning with Shalina in their mission to deliver effective and affordable solutions for pain management to the public.”
Shalina’s Marketing Manager, Mr Chiuba Nwaosu, expressed excitement over the endorsement, noting it as an affirmation of Shalina’s vision to lead in providing quality medications across Africa.
“Our partnership with PSN strengthens our resolve to set higher standards and extend our reach,” Nwaosu remarked. He added that Shalina’s recent investments in a manufacturing facility in Nigeria, which employs over 120 local staff, reflects the company’s commitment to localised, sustainable production.
Beyond IBUCAP capsule, Nwaosu highlighted Shalina’s additional contributions to the healthcare sector, including the SYTA Youth Talent Award programme for pharmacy students across Nigerian universities and the Flying Stars initiative in collaboration with doctors.
He noted that the partnership with PSN further solidifies Shalina’s role in the health sector as both a trusted provider and a supporter of educational and professional development within pharmacy.
The event underscored the joint ambition of both PSN and Shalina to enhance access to effective and affordable healthcare for Nigerians.
R-L: The Director General and Chief Executive Officer of NiMet, Prof. Charles Anosike and The Director General of NCDC, Dr Jide Idris
The Nigerian Meteorological Agency (NiMet) and the Nigeria Centre for Disease Control and Prevention (NCDC) have entered into a Memorandum of Understanding (MoU) focused on data sharing and information exchange to bolster disease preparedness and response in the country.
In a joint statement released on Tuesday via official X handles, both agencies noted that the agreement aims to establish a structured framework for sharing climate and health data. This collaboration, they explained, is designed to enhance situational awareness for climate-sensitive diseases, including cholera and malaria, which are affected by changing weather patterns.
The MoU, which is initially set to run for four years with provisions for renewal, was commended by NiMet’s Director General, Prof. Charles Anosike, as a pivotal achievement. Prof. Anosike highlighted that unpredictable weather patterns pose serious health risks and that the agreement with the NCDC will support better preparedness for climate-related health issues.
“Climate change stands as one of the most significant threats to public health. This collaboration with the NCDC allows us to expand our data systems beyond current capacities, ensuring more robust response mechanisms to climate-induced health crises,” he said, adding that the partnership aligns with the United Nations’ early warning system initiative.” He added
On his part, NCDC Director General, Dr. Jide Idris, underscored the importance of the agreement, noting that it marks a step towards shared data, expertise, and resources. He explained that the collaboration will strengthen Nigeria’s ability to monitor and respond to public health threats linked to climate variables.
“This partnership is not only a step forward for the NCDC and NiMet but also a significant stride in enhancing Nigeria’s resilience to climate-related health challenges,” Dr. Idris said.
In one of the most comprehensive studies on colorectal cancer screening, researchers have found that regular use of the fecal immunochemical test significantly reduces the risk of dying from the condition.
Published in JAMA Network Open, the study concludes that completing one or more fecal immunochemical test screenings lowers colorectal cancer mortality by 33 per cent, with the highest observed for left colon and rectal cancers, where mortality was reduced by 42 per cent.
Fecal immunochemical test (FIT) is a non-invasive screening designed to detect hidden blood in the stool, an early warning sign of colorectal cancer. Fecal immunochemical test is especially valuable because it can be completed at home, bypassing the need for invasive screening procedures like colonoscopies.
According to Dr Chyke A. Doubeni, the study’s lead author, fecal immunochemical test offers a distinct advantage over older tests like the guaiac-based fecal occult blood test (g-FOBT). “Fecal immunochemical test can detect blood from cancers and large polyps with fewer false positives, making it an effective and practical option for regular screening.”
He asserted that its accuracy stems from its ability to specifically detect human hemoglobin in the lower gastrointestinal tract.
The study also highlights that fecal immunochemical testing requires follow-up procedures, such as colonoscopy, if the test result is positive. This ensures that any detected abnormalities are promptly addressed.
The study notes that timely follow-up significantly increases the chances of detecting colorectal cancer early, which is when treatment is most effective.
Dr Douglas Corley, another researcher on the study, emphasised that fecal immunochemical test screening is beneficial because it encourages higher participation rates. “Since the test is simple, many individuals are more likely to complete it unlike when compared to colonoscopy.” He said
“Annual or biennial fecal immunochemical test screening has been shown to reduce colorectal cancer mortality across various population groups,” Corley added.
The researchers analysed data from over 10,000 individuals across two large health systems in the U.S., from 2011 to 2017. The team found that fecal immunochemical test screening was especially effective among non-Hispanic Asians and non-Hispanic Blacks, with reductions in mortality of 63 per cent and 42 per cent, respectively. Non-Hispanic Whites also saw a significant 29 per cent decrease in deaths resulting in colorectal cancer.
“This study provides robust evidence that supports fecal immunochemical test screening as an effective method to prevent colorectal cancer deaths,” Dr Doubeni noted
Funded by the National Cancer Institute, the research followed a diverse population, confirming that the fecal immunochemical test screening is beneficial to all racial and ethnic groups.
While the study showed significant results for cancers in the left colon and rectum, the effectiveness of fecal immunochemical test in detecting right colon cancers was less pronounced, with no statistically significant reduction in mortality. Researchers noted that differences in tumour characteristics and test sensitivity might explain the lower impact of fecal immunochemical test in the right colon.
The findings emphasise how crucial faecal immunochemical testing is to population-based screening programmes, especially in areas with a diverse population in terms of socioeconomic status and race.
The researchers emphasised the need for follow-up colonoscopies after positive fecal immunochemical test results, as timely intervention is critical to improving outcomes.
Although the study presents encouraging results, it recognises certain limitations. These include difficulties in accurately measuring the effects of repeated screenings and the possibility that lifestyle factors, such as diet or exercise, may have influenced the findings. Despite these limitations, the study strongly endorses the ongoing use of fecal immunochemical test as a diagnostic method in colorectal cancer screening programmes.
The study calls for governing bodies and healthcare providers to improve access to fecal immunochemical test screening, particularly in undeveloped regions and high-risk populations, to further reduce the global burden of colorectal cancer.
Pharm. (Elder) Dick Onuigbo, Nigeria’s oldest pharmacist, in the company of Prof Cyril Usifoh, president, PSN (left), Sir Ifeanyi Atueyi, publisher, Pharmanews; Hajia Wasilatu Giwa, chairman, PCN, and Pharm. Deji Osinoiki, at the 97th Annual National Conference of the PSN, in Uyo, Akwa Ibom State.
The Governor of Akwa Ibom State, Pastor Umo Eno; HRM Odidem Bassey Etim Edet, chairman of the Akwa Ibom Traditional Council; alongside other distinguished Nigerians, have lauded the Pharmaceutical Society of Nigeria (PSN) for its nearly century-long commitment to advancing the Pharmacy profession and strengthening the health sector.
Governor Eno conveyed his commendation at the opening ceremony of the PSN’s ongoing 97th Annual National Conference in Uyo, themed “Transforming Pharmaceutical Innovations to Facilitate Equitable Healthcare in an Emerging Economy”, held at Ibom Hall on IBB Avenue, Uyo, graced by numerous health leaders and stakeholders, each affirming the PSN’s impact on public health.
Representing the governor, Hon. (Pastor) Anne Abraham, Senior Special Adviser on General Duties, extended gratitude on behalf of the governor and the late First Lady of Akwa Ibom State, Mrs Patience Umo Eno. She acknowledged the PSN’s efforts in fostering healthcare equity and thanked the Society for its symbolic “walk” in memory of the late First Lady, who shared a profound commitment to the healthcare sector.
L-R; Prof Cyril Usifoh, president, PSN; Prof Stella Usifoh, wife; Hajia Wasilatu Giwa, chairman, PCN, and Hon (Pastor) Anne Abraham, senior special assistant and representative of the Akwa Ibom State Governor, at the Opening Ceremony of the 97th PSN Conference, in Uyo, Akwa Ibom State.
“On behalf of the governor, I welcome the PSN and all distinguished guests to Akwa Ibom State. We are inspired by your dedication to uplifting the Pharmacy profession,” Abraham said
She noted the enduring support of the Akwa Ibom government in maintaining a peaceful state, allowing PSN to hold its conference in a safe and conducive environment. Abraham also acknowledged the role of Mrs Helen Obareki, the “first daughter” of the state, who has been entrusted with the office of the First Lady to oversee initiatives that align with PSN’s healthcare vision.
“We are delighted to collaborate with PSN for the upcoming grassroots health initiative, ‘Wheels of Hope,’ planned for November, saying the programme, running from 11 to 22 November, aims to combat diseases and bring healthcare services closer to underserved communities, with PSN playing an integral role.
In her remarks, Abraham warmly welcomed PSN members and reassured them of the state’s hospitality, saying, “Thank you for choosing Akwa Ibom State for your 97th conference. I am confident this event will foster new partnerships, innovations, and relationships that will elevate healthcare in our state and across Nigeria.”
Also commending the PSN for its dedication to the advancement of pharmaceutical practice and healthcare in the country, Hajia Wasilatu Giwa, chairman, Pharmacy Council of Nigeria (PCN), lauded the leadership of the body for the giant strides in the healthcare sector.
While highlighting the council’s achievements and ongoing reforms, Giwa said the theme, ‘Transforming Pharmaceutical Innovation to Facilitate Equitable Healthcare in an Emerging Economy,’ is fitting for these times as we face challenges such as rising costs of medicines and the impact of the Japa Syndrome.
Urging stakeholders to stay focused on Nigeria’s healthcare renewal agenda, she commended the dedication of the PCN Registrar and announced that the council staff, facing unpaid salaries, will now have financial stability due to recent approvals.
Speaking in the same vein, NAFDAC’s Director General, Prof. Moji Adeyeye, who joined virtually, expressing regret for her absence but praising PSN for its contributions to healthcare advocacy.
She highlighted NAFDAC’s Track and Trace technology, crucial for combating counterfeit medicines, and affirmed NAFDAC’s mission of achieving WHO Maturity Level 4, positioning it as a World Research Authority. “This year’s theme resonates as we work towards equitable healthcare,” she noted, adding that NAFDAC’s work aligns with Sustainable Development Goal 3, which targets quality healthcare for all by 2030.
HRM Odidem Bassey Etim Edet, the Royal Father of the Day, urged PSN to remain steadfast in the fight against counterfeit drugs, calling for collaboration between the PSN and Akwa Ibom to establish a robust pharmaceutical industry. “Let us work together to ensure that only qualified individuals handle pharmaceuticals in our state,” he stated, encouraging PSN’s efforts in protecting lives through quality control in the pharmaceutical sector.
Pharm. Yaro Budah, vice -chairman of the College of Past Presidents, reflected on PSN’s legacy of leadership and guidance in the Pharmacy profession. He paid tribute to the late Professor Ebenezer Ogunlana who died after the last conference in Gombe State.
While celebrating the tenure of outgoing PSN President Prof. Cyril Usifoh, Budah said leadership in PSN is a commitment to inspire and build strong foundations for future generations, recognising the society’s history of steadfast progress.
In his welcome speech, Prof Cyril Usifoh, president of PSN, noted that PSN would continue to champion innovation, collaboration, and dedication to equitable healthcare as it approaches its centennial, calling on the society’s next leadership to continue advancing key milestones achieved during his tenure.
Earlier, the keynote speech with the title, “Transforming Pharmaceutical Innovation to Facilitate Equitable Healthcare in an Emerging Economy”, was delivered by the Coordinating Minister of Health and Social Welfare, Prof Muhammed Ali Pate, who was represented by Dr Obi Adigwe, director general, NIPRD.
The event’s highlight was the special recognition of pharmacists aged 80 and above, including Pharm. (Elder) Dick Onuigbo, Nigeria’s oldest pharmacist, who is set to celebrate his centenary birthday in December. Also honoured were Professor Bona Anayochukwu Obiorah, Pharm. Tunde Elemon, Pharm. (Sir) Ifeanyi Atueyi, and Pharm. Deji Osinoiki, among others.
Pharm. (Elder) Dick Onuigbo, Nigeria’s oldest pharmacist, in the company of Prof Cyril Usifoh, president, PSN (left), Sir Ifeanyi Atueyi, publisher, Pharmanews; Hajia Wasilatu Giwa, chairman, PCN, and Pharm. Deji Osinoiki, at the 97th Annual National Conference of the PSN, in Uyo, Akwa Ibom State.
A cross section of dignitaries and participants at the opening ceremony
L-R, Prof Cyril Usifoh, president, PSN; Prof Stella Usifoh, wife; Hajia Wasilatu Giwa, chairman, PCN, and Hon (Pastor) Anne Abraham, senior special assistant and representative of the Akwa Ibom State Governor, at the Opening Ceremony of the 97th PSN Conference, in Uyo, Akwa Ibom State.
L-R: NIPRD DG, Dr Obi Adigwe, PCN Registrar, Pharm. Babasheu Ahmed, Chairman BoF-PSN, Pharm. Joel Adagadzu and other participants at the opening ceremony of the PSN conference in Uyo.
The Federal Government has called on all stakeholders in the pharmaceutical Industry to join hands with the government so as to actualise the Ministerial Agenda for prioritisation that will increase access to safe and high-quality healthcare in the country.
The Coordinating Minister of Health and Social Welfare, Prof. Muhammad Ali Pate made the call on Tuesday at the opening ceremony of the ongoing 97th Annual National Conference of the Pharmaceutical Society of Nigeria (PSN), holding in Uyo, Akwa Ibom State.
Prof. Pate, who was the keynote speaker at the conference was ably represented by the Director-General/Chief Executive Officer, National Institute for Pharmaceutical Research and Development (NIPRD), Dr Obi Peter Adigwe. The theme of the conference is “Transforming Pharmaceutical Innovation to Facilitate Equitable Healthcare in Emerging Economy”.
The minister explained that medicine security in the country has been prioritised than ever before, noting that the industry has already been positioned for exponential growth that will no doubt translate to increased access to medicines for Nigerians, as well as socio-economic development in various sectors within and outside the Country.
PSN President, Prof. Cyril Usifoh with NIPRD DG, Dr Obi Adigwe shortly after presenting an award to the minister of health Prof. Ali pate at the conference in Uyo.
He noted that the current administration, through the ministry of health has come up with various initiatives and interventions that will enhance medicine security and generally repositioned the nation’s health sector.
Prof. Pate further stated that the ministry came up with thematic pillars which are four areas of priorities, which are governance, population health outcomes, unlocking the healthcare value chain and health security.
According to him, only one of the four areas has been explored and it has brought about many innovations and intervention among which was the presidential executive orders that was recently gazetted by the Federal Government to increase local production of healthcare products and as well reduce cost of healthcare equipment and consumables among others.
He stated that the government is also planning clinical trial centres across the country, adding that the €18 million research on vaccines to be funded by the European Union (EU) is part of the initiatives and intervention to transform the nation’s health sector, adding that more of such intervention will still come.
Recalled that the National Plan for Vaccine Research and Development and Local Production 2024-2034 was presented in Abuja early this year. According to the minister, Medicines’ security is a concept that argues that unless a people exert sufficient control over how their medicines are produced, sustainable access to relevant, affordable, high quality products cannot be guaranteed in that setting.
He specifically noted that the ratio of medicine manufacturers to the nation’s population is currently far from what it ought to be. According to him, there are 170 pharma manufacturers in Nigeria with a population of 0.21 billon, which gives a ratio of 1 pharma manufacturer to 1, 300,000 people, compared to India that has 1.311 billion population and 5000 pharma manufacturers, with a ratio of 1 pharma manufacturer to 260,000 people. He stated that the ministry of health is working vigorously to ensure that the country achieves medicine security, adding that several initiatives and interventions are on the way.
While noting that there is need for more local pharma manufacturers in Nigeria, Prof. Pate said “the Nigerian pharma sector is suitably positioned for exponential growth which will no doubt translate to increased access to medicines for Nigerians, as well as socio economic development in various sectors within and outside the Country.
“All players in the industry must now join hands to actualise the Ministerial Agenda for prioritisation that will increase access to safe and high-quality healthcare. This is the most sustainable approach to achieve medicines’ security whilst also improving the nation’s economy and our people’s livelihood”.
He specifically called on all players in the pharmaceutical industry to work together and develop capacity in the industry. “We need to develop and expand capacity to absorb the space we are creating for the pharmaceutical industry, because if we don’t develop and expand capacity, it is players from other countries that will benefit it”, the minister said.
The outgoing President of the Pharmaceutical Society of Nigeria (PSN), Prof. Cyril Usifoh, has called on the society’s next leadership to continue advancing key milestones achieved during his tenure, saying whoever emerges has his support in order to ensure the Society moves to the next level.
Speaking at the opening ceremony of the 97th PSN Annual National Conference in Uyo, Akwa Ibom State, Prof. Usifoh underscored his administration’s efforts in strengthening the regulation of veterinary and human pharmaceutical practices, improving pharmacists’ welfare, and securing landmark achievements in policy and operational efficiency.
In his address, Prof. Usifoh reflected on his administration’s success in reinforcing the regulatory framework for premises involved in veterinary drug sales. Highlighting a recent judicial ruling, he described the court’s decision as “a sound judgment” upholding the Pharmacy Council of Nigeria’s (PCN) right to oversee veterinary drug outlets in line with its mandate for human pharmacies. This, he emphasised, reflects the robust legal foundation his team established to ensure high standards in veterinary and human pharmacy practices.
Turning to public sector pharmacy welfare, Usifoh commended the strides made under his administration, noting that the PSN was instrumental in the recent Memorandum of Understanding (MoU) with the Federal Government, which sought improved remuneration, consultancy status for pharmacists in federal health institutions, and adjustments in retirement age to 65 for general health workers and 70 for consultants, including pharmacists.
Usifoh noted that his administration worked diligently to actualise these changes, securing a commitment from federal institutions to integrate the consultancy status and related budgeting into their operational plans.
Prof. Usifoh also noted the PSN’s role in advocating for community pharmacists and ensuring their voices were heard on the national stage. He revealed that his administration was vigilant in guarding against legislative amendments that could undermine the Pharmacy Act of 2022. “Your president rose up to the responsibility, rallied stakeholders, and made sure that no clause detrimental to our profession was sneaked in,” he declared.
In a show of fiscal prudence, Usifoh reported that since October 2023, the PSN headquarters had reduced costs by switching entirely to solar power, which now supports the air conditioners. He confirmed that the incoming president would inherit over ₦180 million, accumulated through profits from annual conferences and contributions from alumni and donors.
Looking forward, he encouraged the incoming PSN leadership to “occupy any vacant seat” and continue to expand PSN’s influence in policy and practice. He urged his successor to follow through on significant legislative pursuits, including the Drug Procurement and Distribution Act, the National Postgraduate College of Pharmacy Bill, and amendments to the Fake Drug Act. He also highlighted the PSN’s partnerships in dislodging illegal drug markets and enforcing regulations to curb fake drugs.
The university don also expressed appreciation for the support from PSN members, colleagues, and friends who contributed to his presidency’s successes. He encouraged the next president to uphold the Society’s achievements and drive it towards greater development.
Pharm. (Dr) Charles Ronari Owaba, is the immediate past chairman of PSN Bayelsa State Chapter. He has also served the profession in other capacities as the immediate past secretary of PSN National Investigating Committee and currently a member of the PSN National Publicity Committee. As an aspirant for the position of the PSN National Publicity Secretary, in this engaging interview with Temitope Obayendo, he shares strategies he will deploy to project PPSN’s image as well as advance pharmacists’ interests among policy makers and in the healthcare community. Let’s dive into the conversation:
Please tell us a little about yourself.
I am Pharm. (Dr) Charles Ronari Owaba, the immediate past chairman of PSN Bayelsa State, immediate past secretary of PSN National Investigating Committee and currently a member of the PSN National Publicity Committee.
How do you plan to enhance the visibility and public image of the Pharmaceutical Society of Nigeria, both within the healthcare sector and to the general public?
I will leverage active engagement and coordination of several WHO approved disease awareness days e.g World malaria, hypertension, mental health, hand washing, drug abuse days etc. Additionally, through sponsored appearances on radio and television programmes, the visibility of PSN will be enhanced.
Serious mobilisation through digital media will be done to achieve this by encouraging formation of a vibrant Publicity Committee with members drawn from all state branches. The summary of all this is what I’ve termed Media Blitz in my agenda. I intend to educate managers of media houses how they would be contributing to improving the health indices of Nigeria through dissemination of accurate health information by giving pharmacists slots to discuss critical health issues in the various radio and TV stations, not forgetting the print media.
Given the increasing importance of digital media, what strategies would you employ to improve PSN’s online presence and engagement with members and stakeholders across Nigeria?
The PSN will put into active use, the available social media handles and keep members and stakeholders engaged. Also, I intend to adopt and implement standard media reportage of major PSN activities and regularly upload on the Facebook page. That way, anyone can get important information on current happenings by just visiting the page.
In your view, what role does the PSN Publicity Secretary play in advocacy, particularly in influencing health policies and representing the interests of pharmacists?
The National Publicity Secretary has an abiding duty to be proactive with intelligence gathering of information, to be well abreast of issues in the Pharma space. This guarantees adequate information, guided course and robust engagements in public discourse, health policy advocacy as well as decision making process. Contacts with high profile politicians and top government officials will also help to protect pharmacists interests in policy making. As a person, I have networked with many high profile politicians and I have what it takes to influence policies to favour pharmacists in Nigeria. My track records are there and they speak for me.
Can you provide examples of advocacy campaigns you would lead or support to address critical issues facing pharmacists today?
Collaborative visits to Chief Medical Directors (CMDs) and Medical Directors (MDs) of Federal Health Institutions for full implementation of the Consultant Pharmacists Cadre. This will however be led by the PSN President, but I can initiate the idea and push for it. Another major advocacy I’ll push is reviewing the eligibility criteria for appointment of CMDs & MDs of hospitals as well as Vice-Chancellor (VC) position for universities of medical or health sciences in Nigeria. As it stands now, pharmacists cannot be appointed VCs of medical universities and this is discriminatory.
What initiatives would you implement to foster stronger communication and collaboration among various pharmacy sub-sectors under PSN?
I have an innovative initiative termed SPErM. SPErM is Social to Print and Electronic Media and it aims to take to the mainstream media, valid inputs from valuable discussions held on WhatsApp platforms of pharmacists so that many of the important discussions do not end on social media and then get lost over time.
Pharm.(Dr) Ugochinyere Ogudu is the assistant director of Pharmaceutical Services (ADPS) at the General Hospital, Ikorodu, Lagos. She is also the pharmacist-in-charge of the Mental Health Clinic in Lagos State Rehabilitation Centre, Majidun, Ikorodu, Lagos. A proud alumnus of the prestigious University of Benin, and University of Lagos, where she earned her B. Pharm and Pharm D degrees in 2006 and 2017, respectively, Dr Ogudu is also a Fellow of the esteemed West African Postgraduate College of Pharmacy (WAPCP). As a dynamic youth leader, deeply passionate about the wellbeing of youth and women, she is a candidate for the position of Publicity Secretary at the ongoing 97th PSN National Conference.In this exclusive interview with Temitope Obayendo, she outlines her vision for using various digital media and platforms to advocate for the pharmacy profession, elevate pharmacists’ interests, and build stronger relationships within the healthcare community in Nigeria. She also shares her strategies for driving progress and forging meaningful connections for the advancement of the profession. Enjoy the interesting conversation below:
Can we meet you please ?
I am Pharm. (Dr) Ugochinyere Ogudu. I obtained my first degree as a pharmacist from the prestigious University of Benin where I graduated with both B Pharm(2006} and Pharm D(2007) degrees. I did my one year compulsory internship with the National Agency for Food and Drug Administration and Control (NAFDAC) and was privileged to get experiencial work in all the then six Directorates of Enforcement, Laboratory, Registration and Regulation, Narcotics, Establishment, and Port Inspection. I briefly took a job as Production Pharmacist with BANBIZ pharmaceutical company. I proceeded to the University of Lagos where I acquired Masters degree in Pharmacology, Toxicology and Therapeutics (2017). I also studied and became a Fellow of the glorious West Africa Postgraduate College of Pharmacy where I graduated as a public Health P harms. Presently, I am an Assistant Director of Pharmaceutical Services (ADPS) with Lagos State Health Service Commission working in General hospital Ikorodu with an extended service as the pharmacist in charge of Mental Health Clinic in Lagos State Rehabilitation Center, Majidun. I am very passionate about young people and women wellbeing and have been a youth leader for years.
How do you plan to enhance the visibility and public image of the Pharmaceutical Society of Nigeria, both within the healthcare sector and to the general public?
Our brand which is PSN is already a strong one. However, we need to constantly and consistently engage the members and also the public. I will initiate a system to regularly review our presence on all healthcare platforms and among members of the public. That’s why I said, we have to blow our trumpets, tell our stories by ourselves. We will leverage social media to spread our messages. Also, we engage influencers to market us.
Given the increasing importance of digital media, what strategies would you employ to improve PSN’s online presence and engagement with members and stakeholders across Nigeria?
We are going to optimise our website, making it user secure and friendly. We will then regularly create relevant informational health contents that appeal to our audience. We will be active on social Media, promoting ourselves: who we are and what we do as well as showcasing our awards. We will deliberately promote relevant causes using victuals. We will look out for updates and changes in algorithms.
In your view, what role does the PSN Publicity Secretary play in advocacy, particularly in influencing health policies and representing the interests of pharmacists?
We need to build new relationships and also consolidate the existing ones. Polices are made by government. As PSN Publicity Secretary, it will be my duty to publicly advocate our position on the particular health issue, mobilise allies, and educate supporters as well as opponents.
Can you provide examples of advocacy campaigns you would lead or support to address critical issues facing pharmacists today?
First and foremost, I would love to promote safe medicines use, drug and substance abuse awareness, WHO public health days and weeks campaigns. We will advocate for support of local manufacturers to boost local production. Antimicrobial stewardship will be emphasised as well as pharmacovigilance and proper medicines reconciliations and disposals.
What initiatives would you implement to foster stronger communication and collaboration among various pharmacy sub-sectors under PSN?
The PSN, through my initiatives will strive to build trust among members of the Society. Thereafter, we will seek to resolve conflicts and grievances within groups and among members where such exist. With the understanding of group goals and aspirations, we will engage them. We will also endeavour to maintain a high level of transparency and regularly bring feedbacks. Every group and every pharmacist is very important in making PSN decisions and implementation of policies that concern us. Hence, inclusivity is what we advocate.
Bloom Public Health has equipped stakeholders with advanced knowledge in vaccine manufacturing, through a recent webinar organised by the African Vaccine Academy, in collaboration with Biotech Training Facility, Netherlands and Afrexim bank (AFRACAD).
The virtual event, titled, “Ensuring Data Integrity in Vaccine Manufacturing: A Dive into ALCOA+ Principles of GMP Compliance,” convened industry professionals to dive into the critical role of data integrity in vaccine production, underscoring its significance in maintaining high standards of quality and compliance.
As the demand for vaccines continues to escalate globally, the integrity of data generated throughout the manufacturing process is paramount. The webinar provided participants with an in-depth exploration of the ALCOA+ principles—Attributable, Legible, Contemporaneous, Original, Accurate—alongside additional elements of Complete, Consistent, Enduring, and Available, forming a robust framework for Good Manufacturing Practice (GMP) compliance.
Key insights from the webinar
Comprehensive overview of ALCOA+: Participants gained critical insights into implementing ALCOA+ principles to enhance data integrity within their organisations.
Case studies and best practices: Real-world examples were shared, illustrating the positive impact of rigorous data integrity practices, along with actionable strategies for implementation.
Stakeholders applauded Bloom’s effort in providing a strategic avenue for vaccine experts to cross-fertilise ideas. Speaking after the event, Olutoun Sanusi-Oladunni, senior programme manager, Bloom Public Health, said, ‘’Witnessing this level of engagement from vaccine experts across Africa truly reinforces why I’m so passionate about leading the African Vaccine Academy. We are not just talking about data; we are talking about the foundation for safe, effective vaccines that will protect lives.”
Speaking also, Cynthia De Leeuw, commercial director, Biotech Training Facility, said, “This collaborative spirit, exemplified by AFRACAD, Bloom Public Health, and the Biotech Training Facility, is exactly what is needed to ensure every stage of vaccine production meets the highest standards of integrity and quality. Together, we are building a healthier future for Africa.
“We have joined forces with Bloom Public Health to build the capacity of Africans through our e-learning and hands-on practical sessions, at the Biotech Training Facility, Leiden, Netherlands.”
On his part, Dr James Ayorinde, associate professor of Biochemistry and Molecular Biology, added that the collaboration with Bloom Public Health is impacting positively on the dissemination of technical knowledge expedient to the vaccine ecosystem.
“The heartbeat of the quality of vaccines relies on the quality of data that flows through the vaccine ecosystem’’, he said.
For Stephanie Diagne, assistant manager, export development, ‘’the role of Afrexim bank became crucial in providing financial support during the COVID-19 pandemic. Through several initiatives, we have contributed to healthcare improvement on the African continent.”
While extending his gratitude to all the speakers at the webinar, Prof. Chimezie Anyakora, CEO, Bloom Public Health, said, “The African Vaccine Academy is committed to advancing vaccine education and capacity building across the continent.
“Our vision is to create a sustainable ecosystem of vaccine expertise that supports public health initiatives and improves health outcomes in Africa. We invite stakeholders, partners, and aspiring vaccine experts to join us in our mission’’, he added.
For those who could not attend but wish to revisit the discussions, Anyakora disclosed that recording of the webinar is available through the link here: https://shorturl.at/X4yDN
He explained that Bloom Public Health was born out of the need to create African driven solutions to solve Africa’s public health issues, especially in the pharmaceutical sector. With a presence in six African nations, Bloom Public Health is a leading think tank that convenes the most innovative African minds in public health and forges global partnerships to design interventions that are tailored to the continent.
L-R: Alake of Egbaland, Adedotun Aremu Gladebo; Venerable Collins Babalola; his wife, Prof. Chinedum Peace Babalola, outgoing vice chancellor, Chrisland University and former President Olusegun Obasanje at the valedictory event in Abeokuta.
Former President, Olusegun Obasanjo has applauded Professor Chinedum Peace Babalola, the outgoing Vice-Chancellor of Chrisland University, for her outstanding leadership and dedication to advancing higher education in Nigeria.
Speaking at the valedictory service held in Abeokuta, Ogun State, Obasanjo stated that Babalola’s tenure elevated the institution’s standards, transforming it into one of the top universities in the country.
He hailed her as a “woman of virtue” whose commitment and integrity have left a lasting legacy at Chrisland University. He admonished her contributions to Nigerian educational sector as a whole, noting that her leadership has set a benchmark for future academic leaders.
Addressing the attendees, Obasanjo underlined the need to integrate African cultural values into Nigeria’s democratic framework, advocating for a shift from Western liberal democracy to a more communal, collaborative approach that resonates with African ideals.
He argued that African culture, which emphasises unity and collective problem-solving, aligns more closely with the values necessary to strengthen Nigeria’s democracy.
The Deputy Vice-Chancellor of Chrisland University, Prof. Olatunde Farombi, also recognised Babalola’s achievements in enhancing the university’s reputation and academic quality.
Giving her vote of thanks, Babalola appreciated the founder of Chrisland University, Dr Winifred Awosika, for her steadfast support during her tenure. She assured the university community that she would remain available to offer her expertise and wished the institution continued growth and success.
Residents of the Federal Capital Territory have lamented the high cost of food items, stressing that they are finding it difficult to feed themselves.
The residents also expressed concern over further increases in transportation fares following the rise in the pump price of Premium Motor Spirit, commonly known as petrol.
Speaking to the News Agency of Nigeria on Sunday in Abuja, the residents lamented that the increased fuel price has left them grappling with the harsh realities of rising living costs.
The residents stated that their once manageable budgets have spiralled into a daily struggle, primarily due to soaring food prices and transportation fares.
They appealed to the Federal Government and relevant authorities to take immediate action to address these issues.
A mother of three, Mrs Maryam Abusaid, shared her frustration, stating that she often sits at her kitchen table staring at an empty pot.
“Last year, I could buy a bag of rice for ₦50,000, but now it is more than ₦100,000. How can I feed my children?
“With my husband’s salary barely keeping pace with inflation, I often have to choose between meals and essential household items,” she said.
For civil servant and mother of four, Mrs Ekaite Obot, the situation is no better as she revealed that she has not been able to drive to work or church for the past five months.
“For over five months now, I have not moved my car from the garage because I can no longer afford to fuel or maintain the vehicle.
“The times are really tough for my family. All family expenses have been on me since my husband lost his job as a sales representative.
“I struggle to pay school fees, acquire household items, and feed the family, and with the increasing cost of items, I do not think we can continue to survive on my limited income,” Obot said.
Another civil servant, Mrs Mary Umeh, while lamenting the increased cost of living, said her saving grace was the contribution scheme (adashi) she participates in with some colleagues.
“We have several platforms where we contribute money monthly, and at the end of the year, we use the money to buy various household items.
“It is almost Christmas now, and I do not have any savings, but I am not worried because I know that we will soon use our adashi money to buy some household items.
“I am sure my family will be able to manage the items, and I will just need a little extra money for other things for the Christmas celebration,” she said.
Similarly, a trader, Mr Albert Nwakama, lamented his inability to provide for his family due to low sales from his second-hand clothing business, commonly known as “okrika.”
Nwakama stated that he used to open a new bail of clothing every two to three weeks, but in the past six months, he could barely sell a bail of women’s wear.
“I have not experienced anything like this since I began this okrika business nine years ago. Many customers who used to buy my goods have stopped coming to my shop.
“Even some of those who used to give me money in advance to enable me to open new bails now come to borrow money so they can feed their families.
“People are struggling to eat and care for their families, and buying new clothing is no longer a priority, leaving people like me in a dilemma,” he said.
A teacher, Mrs Nneka Azubuike, remarked that the increased cost of living in the country had turned her into a corporate beggar.
According to Azubuike, every child from a well-to-do family in her class has become a friend due to her selfish reasons.
She said she pays more attention to pupils from wealthy homes because their parents tend to appreciate her for her good deeds.
“I am aware this is unprofessional, but I have to take care of my child because I am a single mother. My salary is not enough to cover our needs.
“I also thought that with the Dangote refinery, fuel prices would reduce and transportation would become affordable in the country, but the reverse is obviously the case.
“The government really needs to find a way to address this transportation issue because it is affecting every sector of the economy, especially food prices,” she said.
For commuter Ibrahim Idris, the surge in transportation fares has significantly impacted his budget for other household necessities.
“I used to spend about ₦400 commuting to the office every day, but now I pay between ₦900 and ₦1,000.
“I am finding it extremely difficult to keep up. I have cut down on most things, yet it is still challenging for me to get to work five times a week,” he said.
On his part, vendor Mr Sule Adams remarked that his formerly booming business has now slowed as many families are tightening their belts.
“We are experiencing a noticeable decline in customers, and some who come to patronise us always want discounts, which we normally oblige because we want to make sales.
“Most customers who used to buy goods in large quantities and store them in their homes now buy smaller amounts due to the increased costs.
“It is hard for us too; we have to pay for our supplies, and if people are not buying from us, we suffer because we have families to take care of,” Adams said.
Additionally, Ms Christabel Nicholas, a small business owner, stated she is facing an uphill battle as she must choose between raising prices, displeasing customers, or absorbing the high costs.
“I have had to increase my prices due to the high cost of items in the market, but my regulars are complaining. It is really a tough decision.
“We need government intervention to overcome this situation because Nigerians are sick, hungry, suffering, and dying,” she said.
NAN reports that the National Bureau of Statistics (NBS), in its Consumer Price Index (CPI) and inflation report for April, showed food inflation increased to 40.53 per cent on a year-on-year basis.
In its July CPI report, the Bureau stated that the headline inflation rate was 9.32 per cent higher than the rate recorded in July 2023, which was 24.08 per cent.
The increase in the headline index for July, both on a year-on-year and month-on-month basis, was attributed to the rise in prices of certain goods and services at the divisional level.
Nigerian paediatricians, under the umbrella of the Paediatric Association of Nigeria (PAN) have tasked the Federal Government and state governments on urgent and effective implementation of Child Rights Act, which hitherto has encountered several setbacks, thereby making the Nigerian child an object of deprivation and molestation of all forms. They particularly decried the pitiable physical state of the children among a group that was recently arraigned at the Federal Court in Abuja.
The children specialists, also urge governments to intensify agricultural initiatives, and focus on reducing the out-of-school population, emphasising that these steps are crucial to safeguarding the rights and future of Nigerian children.
They express grievous concerns over the deteriorating state of child welfare in the country, highlighting economic challenges and social issues that threaten the survival and quality of life of Nigerian children. In press statement jointly signed by PAN National President, Dr Ekanem Nsikak Ekure, and Secretary, Dr Chika Duru, they described Nigerian children as “endangered species” due to growing vulnerabilities linked to poverty, insecurity, and insufficient enforcement of the Child Rights Act.
As the voice of Nigeria’s youth, Ekure calls on government agents to uphold child protection laws and to act decisively to prevent any further deprivation and harm to the nation’s children. She underscores that a brighter future for Nigeria is only possible by ensuring a healthy and safe environment for every child.
Ekure, a professor of Paediatric Cardiology, at the College of Medicine, University of Lagos, and also honarary consultant, at the Lagos State University teaching Hospital, draws attention to the worsening conditions Nigerian children face today compared to previous years, when they could enjoy moments of play and recreation despite societal struggles with malnutrition and disease. Today, however, she asserted that children face the daily dangers of kidnapping, ritual killings, sexual abuse, and unjust detentions. She pointed to recent reports of children appearing in court in visibly distressed states, underscoring the severity of the current crisis.
PAN National President, Dr Ekanem Nsikak Ekure
She said Nigeria’s economic challenges over the past months have worsened conditions for many families. With the currency losing value and the cost of living rising, households are struggling to provide basic needs, making children particularly vulnerable. She warns that the current trajectory could undo years of progress made in child survival rates and hinder Nigeria’s ability to meet Sustainable Development Goal 3, which focuses on good health and well-being.
According to her, “Food insecurity and malnutrition are key concerns, as nearly 38 per cent of children under five are stunted, 18 per cent are wasted, and 22 per cent are underweight—figures that exceed global averages. PAN anticipates that childhood malnutrition rates could further escalate as economic pressures persist, amplifying risks to health and development for Nigeria’s youngest citizens.”
The PAN President also laments the widening gap between the Child Rights Act’s promises and its actual implementation. The act, intended to protect children’s rights to dignity, nutrition, health, education, and security, remains largely unfulfilled at both federal and state levels. She therefore calls for stricter enforcement to ensure that no child is subjected to detention or captivity that violates these fundamental rights.
“The country’s educational challenges compound these issues, with one in three Nigerian children reportedly out of school. Nigeria contributes 15 per cent of the global out-of-school population, a statistic PAN describes as a “reservoir for socially disgruntled adults” that could pose future threats to the nation’s stability. PAN emphasises the urgent need to address the socio-cultural factors driving children out of school,” she stated.
While commending federal efforts to improve family welfare, such as raising the minimum wage for government workers, Ekure avers that more needs to be done. She emphasises need to reduce insecurity is essential to supporting agricultural activity, which could enhance food security and help achieve Sustainable Development Goal 2, focused on eradicating hunger.
Last month, we explored the impact of non-communicable diseases (NCDs) and the burden they place on society and families. The rise in NCDs is closely tied to several factors, including rapid urbanisation and lifestyle changes.
Poor dietary habits and increasingly sedentary lifestyles have contributed significantly to the rise of obesity, high blood pressure, and high cholesterol—key risk factors for many NCDs. The increasing prevalence of smoking, alcohol consumption, and air pollution also fuels the rise of these diseases.
In Africa, the situation is compounded by weak healthcare infrastructure and a lack of awareness about early detection and prevention. According to a 2018 WHO report, Africa is projected to experience the highest increase in deaths from NCDs between 2010 and 2030. If interventions are not scaled up, NCDs could overwhelm fragile healthcare systems and reverse progress made in tackling infectious diseases.
Ironically, while technological and medical advancements have helped eradicate or control many communicable or infectious diseases, they have done little to slow the rise of NCDs. In many cases, modern conveniences—such as processed foods and digital gadgets that encourage inactivity—have exacerbated this epidemic.
Role of healthcare providers
In the face of this growing challenge, healthcare providers—particularly pharmacists—play a critical role in alleviating the burden of NCDs. Pharmacists are often the most accessible healthcare professionals in many communities, making them key allies in this fight.
Medication management and adherence
Many NCDs require long-term management through medication, but poor adherence to treatment regimens remains a major obstacle. Pharmacists are uniquely positioned to manage medication therapy for patients with chronic conditions like diabetes, hypertension, and asthma.
Poor medication adherence is a major factor that worsens NCDs, and pharmacists can intervene by offering counselling, medication synchronisation, and reminders to ensure patients take their medications consistently. For example, studies have shown that pharmacist-led interventions can significantly improve medication adherence in hypertensive patients, leading to better blood pressure control and reduced risk of cardiovascular events.
Early screening and risk assessment
Pharmacists are also well-positioned to offer screening services for conditions such as hypertension, high cholesterol, and diabetes; they can take on roles in prevention and early detection. In many low-resource settings, community pharmacies serve as primary points of care, providing essential health checks that can detect diseases early. Pharmacists can help identify at-risk individuals and refer them to appropriate healthcare providers for further management.
Lifestyle counselling and education
Given that NCDs are largely preventable through lifestyle changes, the importance of education cannot be overstated. Pharmacists can empower patients to make informed choices about their diet, exercise, and habits, which can go a long way in preventing or managing NCDs. Through regular engagement with patients, pharmacists can reinforce healthy behaviours and offer practical advice tailored to individuals’ needs.
Education and advocacy
Pharmacists are in a unique position to advocate for greater awareness of NCDs. By educating their communities, they can help shift the narrative from treatment to prevention, empowering individuals to take control of their health. Pharmacists can also advocate for policies that promote healthier lifestyles and improve access to care, especially in underserved areas.
Policy development
Pharmacists can influence healthcare policy, particularly when it comes to access to medications and preventive services. By participating in policy-making processes and advocacy efforts, pharmacists can help ensure that NCD management is prioritised on national healthcare agendas. In Nigeria, for instance, pharmacists can advocate for policies that improve access to affordable medications and strengthen NCD awareness campaigns.
Have we truly lost the fight?
The statistics may seem grim, but the fight against NCDs is far from lost. While we are currently facing an uphill battle, the reality is that NCDs are largely preventable and manageable. The numbers are staggering, but there are pathways to change—preventive care, lifestyle modification, and better access to healthcare.
The rise of NCDs does not signify a lost war, but rather a call to action. Countries that have implemented comprehensive strategies to tackle NCDs—such as policies to reduce tobacco use, promote physical activity, and improve access to healthcare—have seen declines in mortality rates from these diseases.
However, more needs to be done, particularly in low-resource settings like sub-Saharan Africa. Collaboration between government agencies, healthcare providers, and community organisations is key to scaling up interventions.
Pharmacists must be at the forefront of these efforts, helping to reduce the incidence and impact of NCDs. They have the knowledge, access, and trust needed to influence patient behaviour, improve treatment outcomes, and help communities manage these diseases more effectively.
Pharm. (Mrs) Oyinkansola Ejoor is a distinguished pharmacy professional, currently managing the pharmacy unit at Chevron Nigeria Limited.
Her academic journey began at Maryhill Convent School, Ibadan, for her primary education, followed by International School, University of Ibadan, for her secondary education. She then earned a Bachelor’s degree in Pharmacy from Obafemi Awolowo University.
Ejoor’s quest for knowledge led her to pursue a master’s degree in Pharmaceutics and Industrial Pharmacy from the University of Ibadan. She further advanced her academic credentials with an MBA and an MRes from the University of Liverpool. Recently, she completed a doctorate in Business Administration, adding another prestigious feather to her cap.
Her professional career began at General Hospital, Isolo, where she had her National Youth Service Corps (NYSC) programme. Afterwards, she joined Olly Chemist, Ibadan, a pharmaceutical manufacturing company founded by her late father, Pharm. C. O. Odunsi, a Fellow of the Pharmaceutical Society of Nigeria.
Fondly known as “Oyinkan,” Ejoor has been instrumental in leading numerous patient-centred care initiatives and quality improvement programmes that have significantly enhanced medication use, prescribing practices, patient outcomes, and the overall quality of life for her patients. These initiatives span medication reconciliation, antibiotic stewardship, medication utilisation reviews, supply chain inventory management, quality indicators, and medication safety practices.
With a proven track record of success, Ejoor’s leadership extends beyond the professional sphere. She is an ordained official in her church and plays an active role as a youth pastor, focusing on nurturing moral values and personal development in young people.
Pharm. Ejoor is happily married and a proud mother, seamlessly balancing her family life with her professional and spiritual commitments. Her dedication, diligence, and drive for excellence make her a respected figure in the pharmacy profession and beyond.
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued an urgent advisory, warning Nigerians against the use of Nivea Black & White Invisible Body Deodorant, produced by Beiersdorf AG, a Germany-based multinational known for personal care products.
According to NAFDAC, the deodorant has been recalled in Europe due to the presence of 2-(4-tert-Butylbenzyl propionaldehyde), also known as BMHCA, a chemical prohibited for use in cosmetics due to health risks.
In a statement issued on Thursday via it’s Official X platform, NAFDAC described the risks posed by BMHCA, explaining that the chemical could cause skin irritation and has been linked to potential harm to reproductive health and risks for an unborn child. “The recalled Nivea product is said to contain 2-(4-tert-Butylbenzyl propionaldehyde (BMHCA), a chemical prohibited in cosmetic products due to its ability to cause harm to the reproductive system, impair the health of an unborn child, as well as skin irritation and burns to users,” NAFDAC stated.
The agency noted that the product is listed on the European Union’s Rapid Alert System for Dangerous Non-Food Products (RAPEX), with authorities in Brussels identifying the chemical as unsafe for consumer use. NAFDAC further clarified that the Nivea Black & White Invisible series, which markets itself as a “no-stains” deodorant, is designed to prevent deodorant marks on clothing but remains unsuitable for use due to the identified health hazards.
NAFDAC urged importers, distributors, and consumers to discontinue the sale and use of the product. “Importers, distributors, retailers, and consumers are advised to exercise caution and vigilance within the supply chain to avoid the importation, distribution, sale, and use of the above-mentioned Nivea Roll-on with the affected batch. Members of the public in possession of the affected batch of product should discontinue the sale or use and submit stock to the nearest NAFDAC office,” the agency advised.
NAFDAC requested healthcare professionals and the public to report any adverse reactions related to this or other regulated products via its pharmacovigilance channels.
African oil bean seed, commonly known as ugba, with scientifical name as Pentaclethra macrophylla, is a fermented food widely consumed in southeastern Nigeria. Its incredible health benefits for your overall wellness has been affirmed by numerous empirical studies.
Known as a powerhouse of protein, and essential minerals like calcium and magnesium, it supports strong bones and healthy muscles. Ugba is also found to be rich in antioxidant that help protect the body from oxidative stress, reducing inflammation and the risk of chronic diseases like heart diseases.
What makes ugba even more special is the fermentation process, which not only boosts the absorption of these nutrients but also introduces probiotics that improve gut health and digestion. These probiotic bacteria are said to also strengthen the immune system.
Enjoyed as a condiment in dishes like African salad (abacha) or prepared for special occasions, it is one of the most beloved delicacies in the Igbo culture. The fermentation process, which involves boiling, slicing, and wrapping the seeds in banana leaves, takes place over several days. This traditional method of preparation i.e its fermentation, not only births its unique flavour but also contributes to its numerous health benefits.
Historically, ugba has a significant place in Igbo culture, serving as both a food and a symbolic item in communal and social events. The fermentation of African oil bean seeds dates back centuries, reflecting the deep-rooted importance of this food in local delicacies. Ugba is typically produced in households or by small-scale producers, and it is highly regarded for its protein-rich content.
However, its value extends far beyond cultural symbolism, as recent studies have highlighted the profound health benefits associated with its consumption.
Fermentation process
The process of fermenting ugba can be said to be complex and labour-intensive, involving several stages. The African oil bean seeds, which are hard and inedible in their raw state, are first boiled for several hours to soften them. After boiling, the seeds are sliced into thin strips and wrapped in banana leaves to ferment at ambient temperatures. This process, which takes 3–5 days, allows beneficial microorganisms to break down the seed’s tough fibres, releasing nutrients and enhancing its flavour.
As described by Francis Anosike and others in the journal of Applied Food Research, the fermentation of ugba is an alkaline process that creates a favourable environment for probiotic bacteria. These bacteria contribute to both its preservation and the enhancement of its health properties. Notably, ugba’s fermentation is primarily driven by Bacillus species, which are known for their ability to produce enzymes that aid in protein digestion and nutrient absorption.
The health benefits of Ugba, according to several research studies, are as follows:
Rich source of protein
Chika Ogueke and colleagues, in a study published in the Pakistan Journal of Nutrition, identified ugba as a rich source of protein, essential amino acids, and minerals such as calcium, magnesium, and phosphorus. These nutrients are vital for bone health, muscle function, and general well-being. The study further indicates that the fermentation process increases the digestibility of these nutrients, allowing for better absorption in the body.
Balances gut microbiome
Scientists from the Department of Agriculture at Alex Ekwueme Federal University, have also highlighted the probiotic potential of ugba. According to the study, published in the journal of Applied Food Research, ugba’s fermentation introduces good bacteria, especially Lactobacillus and Bacillus strains that promote gut health. These probiotics improve the intestinal microbial balance, enhance digestion, and strengthen the immune system by stimulating the production of antimicrobial compounds.
Also, a study by Ogueke and colleagues supports this claim by showing that regular consumption of probiotic-filled foods like ugba can help alleviate gastrointestinal issues, including diarrhoea and constipation, due to the probiotics’ role in maintaining a healthy gut microbiome.
Antioxidant and anti-inflammatory benefits
Findings by Alo Isaac and his team suggests that ugba contains powerful antioxidants that help counter oxidative stress, a key contributor to chronic conditions such as cancer and heart disease. The research published in the International Journal of Food Microbiology, shows antioxidants are known for neutralising free radicals, which are unstable molecules that cause cellular damage. However, the anti-inflammatory properties of ugba may aid in reducing inflammation.
Helps improve cardiovascular health
Additionally, ugba is found to be low in saturated fats and contains heart-healthy unsaturated fats. According to research published by Chika Ogueke and her team in the Pakistan Journal of Nutrition, it indicates that consuming ugba can help lower levels of bad cholesterol (LDL), reducing the risk of cardiovascular diseases like atherosclerosis. The fermentation process also reduces the fat content, making ugba an excellent choice for maintaining heart health.
In summary, its rich protein content, probiotic components, antioxidants, and heart-healthy fats make ugba an essential food that is worth giving a try.
Our life purpose is a process, it is not a quick fix. It is not like fast food which will satisfy your appetite but provide you with little nutritional value. One of my favourite songs says, “Breathe on me breath of God, until my heart is pure, until my will is one with thine, to do and to endure.” Purpose leads to greatness when you are properly connected to the source.
Jesus said, “Without me you can do nothing.” John 15:5. One benefit of being constantly in tune with God is that when you deviate from your purpose, He brings you back to the right track because He wants you to fulfil your destiny. Have you ever watched a shepherd moving along with his sheep? Occasionally, one or two stray away, what the shepherd does is to move a little faster to redirect the one going astray and bring it back to the fold. Our God is the good shepherd.
The pointer of a compass always points to the true north. If you turn the compass to the east, west or south, it still returns to the north direction. This is what the attribute of purpose should be. Your wrong direction may be God’s plan. He allows you to make a detour to teach you a lesson. He allowed the Israelites to wander in the wilderness for 40 years for a purpose. However, when you veer in the wrong direction, you will know because it is not the right way to true prosperity.
If you find yourself in such a situation, retrace your steps like the prodigal son as quickly as possible. Don’t lose your bearing for too long, like a ship without a compass or a sheep without a shepherd. We are all created as unique individuals in order to make a difference. Success comes from making that difference. In other words, without making a difference, there is no basis for claiming success or significance.
The pursuit of purpose is the process of fulfilling destiny. The enemy of your soul knows your purpose and constantly works to frustrate it. Deviation from your purpose results in failure, which is success to the enemy. Therefore, you must be alert, watch, and pray. “Be sober, be vigilant, because your adversary, the devil, as a roaring lion, walketh about, seeking whom he may devour.”
1st Peter 5:8. The process of purpose is usually full of challenges, but you can overcome the challenges by the power of God. To fight the devil does not require tangible weapons as our soldiers use in fighting the Boko Haram insurgents. We are fighting a spiritual warfare and not a physical one.
Even the so-called physical warfare is preceded by the spiritual one.
2nd Corinthians 10:4 says, “For the weapons of warfare are not carnal, but mighty through God to the pulling down of strongholds.” God is also concerned about your environment because you are a product of your environment. Your environment greatly influences your destiny. Many years ago, a good friend in the US advised me to apply for an immigrant visa and relocate. It was a good opportunity.
Many have relocated, but the question is, am I among the ones to relocate? Where am I destined to be? There’s a place one should be and a place one should not be. In Genesis 12:1, God gave a definite instruction to Abram: “Leave your country, your people, and your father’s household, and go to the land I will show you.” God moved him out of Ur of the Chaldeans for him to become the person he should be. If he had stayed in his own country, he would have missed his blessing.
In the case of his son Isaac, he was in the land of the Philistines when there was a famine and his counterparts were migrating to Egypt. But the Lord told him,” Do not go down to Egypt. Live in the land where I tell you to live. Stay in this land for a while and I’ll be with you and will bless you.” Genesis 26:2-3. Disobedience is a great enemy of purpose.
Stay in this land for a while and I’ll be with you and will bless you.” Genesis 26:2-3. Disobedience is a great enemy of purpose. Do not be like King Saul who lost his crown because of his partial obedience. God demands complete obedience from all who desire to fulfil their purpose.
Last month, we explored the impact of non-communicable diseases (NCDs) and the burden they place on society and families. The rise in NCDs is closely tied to several factors, including rapid urbanisation and lifestyle changes.
Poor dietary habits and increasingly sedentary lifestyles have contributed significantly to the rise of obesity, high blood pressure, and high cholesterol—key risk factors for many NCDs. The increasing prevalence of smoking, alcohol consumption, and air pollution also fuels the rise of these diseases.
In Africa, the situation is compounded by weak healthcare infrastructure and a lack of awareness about early detection and prevention. According to a 2018 WHO report, Africa is projected to experience the highest increase in deaths from NCDs between 2010 and 2030. If interventions are not scaled up, NCDs could overwhelm fragile healthcare systems and reverse progress made in tackling infectious diseases.
Ironically, while technological and medical advancements have helped eradicate or control many communicable or infectious diseases, they have done little to slow the rise of NCDs. In many cases, modern conveniences—such as processed foods and digital gadgets that encourage inactivity—have exacerbated this epidemic.
Role of healthcare providers
In the face of this growing challenge, healthcare providers—particularly pharmacists—play a critical role in alleviating the burden of NCDs. Pharmacists are often the most accessible healthcare professionals in many communities, making them key allies in this fight.
Medication management and adherence
Many NCDs require long-term management through medication, but poor adherence to treatment regimens remains a major obstacle. Pharmacists are uniquely positioned to manage medication therapy for patients with chronic conditions like diabetes, hypertension, and asthma.
Poor medication adherence is a major factor that worsens NCDs, and pharmacists can intervene by offering counselling, medication synchronisation, and reminders to ensure patients take their medications consistently. For example, studies have shown that pharmacist-led interventions can significantly improve medication adherence in hypertensive patients, leading to better blood pressure control and reduced risk of cardiovascular events.
Early screening and risk assessment
Pharmacists are also well-positioned to offer screening services for conditions such as hypertension, high cholesterol, and diabetes; they can take on roles in prevention and early detection. In many low-resource settings, community pharmacies serve as primary points of care, providing essential health checks that can detect diseases early. Pharmacists can help identify at-risk individuals and refer them to appropriate healthcare providers for further management.
Lifestyle counselling and education
Given that NCDs are largely preventable through lifestyle changes, the importance of education cannot be overstated. Pharmacists can empower patients to make informed choices about their diet, exercise, and habits, which can go a long way in preventing or managing NCDs. Through regular engagement with patients, pharmacists can reinforce healthy behaviours and offer practical advice tailored to individuals’ needs.
Education and advocacy
Pharmacists are in a unique position to advocate for greater awareness of NCDs. By educating their communities, they can help shift the narrative from treatment to prevention, empowering individuals to take control of their health. Pharmacists can also advocate for policies that promote healthier lifestyles and improve access to care, especially in underserved areas.
Policy development
Pharmacists can influence healthcare policy, particularly when it comes to access to medications and preventive services. By participating in policy-making processes and advocacy efforts, pharmacists can help ensure that NCD management is prioritised on national healthcare agendas. In Nigeria, for instance, pharmacists can advocate for policies that improve access to affordable medications and strengthen NCD awareness campaigns.
Have we truly lost the fight?
The statistics may seem grim, but the fight against NCDs is far from lost. While we are currently facing an uphill battle, the reality is that NCDs are largely preventable and manageable. The numbers are staggering, but there are pathways to change—preventive care, lifestyle modification, and better access to healthcare.
The rise of NCDs does not signify a lost war, but rather a call to action. Countries that have implemented comprehensive strategies to tackle NCDs—such as policies to reduce tobacco use, promote physical activity, and improve access to healthcare—have seen declines in mortality rates from these diseases.
However, more needs to be done, particularly in low-resource settings like sub-Saharan Africa. Collaboration between government agencies, healthcare providers, and community organisations is key to scaling up interventions.
Pharmacists must be at the forefront of these efforts, helping to reduce the incidence and impact of NCDs. They have the knowledge, access, and trust needed to influence patient behaviour, improve treatment outcomes, and help communities manage these diseases more effectively.
By Pharm. (Dr) Onyinye Chiekwe Bridget, PharmD, MPH, ABMP
WHO Country Representative and Head of Mission to Nigeria, Dr Walter Mulombo
The World Health Organisation (WHO) has called on Nigeria to incorporate Artificial Intelligence (AI) in its disease surveillance systems to enhance public health response efforts. WHO Country Representative and Head of Mission to Nigeria , Dr Walter Mulombo, highlighted the importance of AI at the opening of the 5th Annual Disease Surveillance Review Meeting organised by the Nigerian Centre for Disease Control and Prevention (NCDC) in Lagos.
Dr Mulombo emphasised that integrating AI could significantly improve Nigeria’s capacity to detect, prevent, and respond to health emergencies, stating that “AI has the potential to revolutionise global health security by enabling more proactive, data-driven approaches to health threats.”
He added that such technologies could help reduce morbidity, mortality, disability, and the economic disruption caused by disease outbreaks and other health emergencies in the African region. However, he cautioned that challenges related to data privacy, security, and ethical deployment must be addressed.
Additionally, Mulombo advocated for the One Health framework, a collaborative approach that links human, animal, and environmental health to better address health threats. He noted that this approach could help Nigeria re-evaluate its surveillance interventions, as many infectious diseases originate from animal and environmental sources. The One Health strategy has been in place in Nigeria since 2019, promoting a comprehensive, multisectoral approach to health surveillance.
Funding was also identified as a critical challenge for Nigeria’s disease surveillance. Mulombo highlighted that financing gaps are a barrier for many nations striving to meet the 2030 global health targets, with additional funding mechanisms necessary to support countries in responding effectively to health threats.
Drector General of the NCDC, Dr Jide Idris, affirmed the need for robust surveillance at all levels of society, noting that “true health security begins at the grassroots— in towns, villages, and neighborhoods.” He stressed that every preventive measure at the community level strengthens Nigeria’s overall health security.
The meeting, themed “Strengthening Global Health Security Through Enhanced Disease Surveillance,” held from October 28 to 30 and brought together state epidemiologists, frontline workers, and other stakeholders to review surveillance activities and propose solutions to identified challenges.
Dr. Fatima Saleh, NCDC’s Director of Surveillance and Epidemiology, noted that the annual event provides an opportunity to update and improve surveillance activities across Nigeria.
A cross-section of the graduating pharmacy students of Chukwuemeka Odemegwu Ojukwu University, at their oath taking/induction ceremony recently.
The Faculty of Pharmaceutical Sciences, Chukwuemeka Odumegwu Ojukwu University (COOU), Igbariam, recently graduated 128 new pharmacists, all of whom were inducted into the pharmacy profession by the Pharmacy Council of Nigeria (PCN).
The graduates were inducted during the third oath-taking and induction ceremony held at the university.
Speaking before administering the oath, the Registrar of the PCN, Pharm. Babashehu Ahmed, represented by Dr Anthony Idoko, urged the inductees to maintain ethical standards in their professional conduct. He also encouraged them to work towards the advancement of the Nigerian healthcare sector, emphasising that they should be exemplary ambassadors for the pharmacy profession.
The registrar highlighted the PCN’s strong stance against professional misconduct and advised the inductees to avoid actions that could tarnish the reputation of the profession.
In his address, the Dean of the Faculty, Prof. Theophine Chinwuba Akunne, noted that the graduates had undergone rigorous academic training over five years and had been deemed worthy in both character and learning to practise pharmacy in Nigeria and beyond.
The Dean said, “Rest assured that you have acquired the necessary knowledge and skills during these five years of intensive training, which will enable you to practise pharmacy with confidence and contribute meaningfully to global healthcare.”
He continued, “In line with the three ‘V’s mantra of our esteemed Vice-Chancellor, Prof. Kate Omenugha—value, viability, and visibility—you are challenged to go out into the wider society and pharmaceutically add value, be morally and mentally viable, and, above all, remain professionally visible and outstanding.”
Akunne also expressed his gratitude to the acting VC for her support of the Faculty within her short time in office, noting the positive impact she had already made.
“These few months of your leadership at Chukwuemeka Odumegwu Ojukwu University have been incredibly beneficial to both the university and our Faculty,” the dean remarked.
Meanwhile, the faculty is preparing to launch its Doctor of Pharmacy (PharmD) programme. Akunne announced that the PharmD programme will begin in the next academic session.
He commended the VC for her efforts in securing the Senate approval for the programme.
“You facilitated the Senate’s approval for the six-year Doctor of Pharmacy (PharmD) programme, as well as the professional Diploma (part-time) in Herbal Medicine and Nutrition. Under your guidance, these two programmes will commence in the upcoming academic session,” the dean said.
The highlight of the event was the presentation of various awards and prizes, with Pharm. Wendy Ozoh receiving the award for the best graduating student, alongside other outstanding graduates.
In the competitive world of pharmaceutical sales in Nigeria, the ability to build and maintain strong relationships is paramount. For sales managers, these relationships are not just transactional; they form the foundation of trust, loyalty, and long-term success. This article explores the critical components of relationship-building, including enhancing key relationships with customers, engaging with them daily, and fostering meaningful connections within the industry.
Enhance your key relationships (customers, HCPs, retailers, etc.)
Building strong relationships with customers, healthcare professionals (HCPs), and retailers is essential for driving sales and ensuring customer loyalty. Sales managers must prioritise understanding the unique needs and preferences of these stakeholders to create tailored solutions that meet their expectations.
Strategies for enhancing key relationships
Personalise interactions: Take the time to understand each customer’s specific needs and preferences. Personalising interactions can make customers feel valued and appreciated, fostering loyalty.
Provide value beyond sales: Offer insights, resources, and support that go beyond the sale of products. By positioning yourself as a trusted advisor, you can strengthen relationships and encourage repeat business.
Follow up regularly: Consistent follow-up demonstrates commitment and reliability. Use follow-up calls or emails to check in on customers, address any concerns, and reinforce your availability for support.
Engage with customers daily
Regular engagement with customers is crucial for maintaining strong relationships and staying attuned to their evolving needs. Sales managers should make it a priority to connect with customers on a daily basis, whether through direct interactions, phone calls, or digital communication.
Tips for daily customer engagement
Schedule regular check-ins: Set aside time each week for scheduled check-ins with key customers. These conversations can provide valuable insights into their experiences and needs.
Utilise technology: Leverage customer relationship management (CRM) tools to track interactions and preferences. This technology can help you stay organised and ensure that you are consistently engaging with customers.
Be approachable and responsive: Foster an open line of communication by being readily available for questions and concerns. Quick responses to enquiries can significantly enhance customer satisfaction and loyalty.
Build meaningful relationships for networking
Networking is a vital aspect of sales success, and building meaningful relationships within the industry can open doors to new opportunities. Sales managers should actively seek to connect with colleagues, industry leaders, and other professionals to expand their network and enhance their influence.
Strategies for effective networking
Attend industry events: Participate in conferences, trade shows, and networking events to meet new contacts and strengthen existing relationships. Engaging with industry peers can provide valuable insights and opportunities for collaboration.
Join professional associations: Becoming a member of professional organisations related to the pharmaceutical industry can facilitate networking and provide access to resources and support.
Leverage social media: Use platforms like LinkedIn to connect with industry professionals, share insights, and engage in discussions. Social media can be a powerful tool for expanding your network and building relationships.
Takeaway
Building strong relationships is a cornerstone of sustained success in pharmaceutical sales. By enhancing key relationships with customers, engaging with them daily, and fostering meaningful connections within the industry, sales managers can create a robust network that supports their growth and success.
As we continue this series on essential mindsets, behaviours, and practices for salespeople in Nigeria, the next article will focus on Achieving Financial Responsibility: A Crucial Step in Staying Ahead as a Sales Manager. This article will explore the importance of financial literacy, debunk the myths surrounding instant wealth, and emphasise the significance of financial discipline for long-term stability. Stay tuned for insights that will empower you to take control of your financial future while excelling in your sales career.
Tunde Oyeniran, B Pharm, MBA, FSPMN, a Sales/Marketing Strategist, Selling/Sales Management Trainer, and Personal Sales Coach, is the Lead Consultant at Ekini White Tulip Consulting Limited (eWTC), Lagos. eWTC provides training, recruitment, online CME/medico-marketing, and field force management solutions services.
Feedback Channels: 080-2960-6103 (SMS/WhatsApp) / ekiniwhitetuliptraining@gmail.com or check out https://fb.me/EkiniWhiteTulipConsulting
Nigeria is a country rich in cultural diversity, abundant natural resources, and resilient people. Yet, it faces significant health challenges, with malaria being one of the most critical. This mosquito-borne disease continues to claim lives and hinder economic development, particularly in rural areas. Exacerbating the situation is a growing phenomenon known as “paracetamia,” a term that encapsulates the over-reliance on paracetamol as a primary treatment for malaria symptoms, often leading to misdiagnosis and inadequate care.
Malaria remains one of Nigeria’s most pressing public health issues, with the World Health Organisation (WHO) estimating that the country accounts for a substantial percentage of global malaria cases. Factors such as poor healthcare infrastructure, limited access to preventive measures like insecticide-treated nets, and a lack of awareness about the disease contribute to its prevalence.
Children under five and pregnant women are particularly vulnerable. The symptoms of malaria—fever, chills, and fatigue—often overlap with other illnesses, making accurate diagnosis challenging. As a result, many people resort to self-medication, typically with readily available over-the-counter drugs like paracetamol, to alleviate their symptoms without seeking proper medical attention.
“Paracetamia” refers to the widespread practice of using paracetamol as a go-to treatment for fever and pain, particularly in situations where malaria is suspected. In Nigeria, it is common for individuals to take paracetamol at the first sign of a fever, hoping it will address the underlying issue. This practice is not only dangerous but also indicative of a larger systemic issue: the lack of accessible and effective healthcare.
While paracetamol can be an effective pain reliever and fever reducer, it does not treat malaria. This misuse leads to a cycle of misdiagnosis. Patients may experience temporary relief from their symptoms, delaying their visit to healthcare providers, which can result in severe complications or even death.
The ramifications of “paracetamia” extend beyond individual health. Self-medication can mask the symptoms of malaria, allowing the disease to progress unchecked. When patients eventually seek medical help, they often present with severe cases, complicating treatment and increasing the likelihood of adverse outcomes.
Moreover, the tendency to self-medicate creates a barrier to accurately understanding the malaria burden in Nigeria. Public health statistics may underreport malaria cases because individuals do not seek formal diagnosis and treatment. This data gap makes it challenging for health authorities to develop targeted interventions and allocate resources effectively.
Addressing “paracetamia” requires a multifaceted approach, beginning with education. Public health campaigns should aim to raise awareness about malaria, its symptoms, and the importance of seeking medical advice. Community health workers play a crucial role in this education, as they often serve as the first point of contact for health-related issues in rural areas.
Schools can also be instrumental in disseminating knowledge about malaria. By incorporating health education into the curriculum, children can learn about prevention methods and the importance of seeking proper medical treatment for fevers. This knowledge can be passed on to their families, creating a ripple effect that can improve community health outcomes.
Improving access to healthcare is another critical step in combating “paracetamia.” Many Nigerians, particularly in rural areas, face significant barriers to accessing medical care, including long distances to healthcare facilities and high costs. Expanding community clinics and providing mobile health services can bridge this gap, ensuring that individuals receive timely diagnoses and appropriate treatments for malaria.
Moreover, training healthcare providers to recognise the signs of malaria and to educate patients on the dangers of self-medication is essential. This training can foster a more informed patient population that understands the importance of proper medical care, leading to better health outcomes.
Technology can play a pivotal role in addressing malaria and “paracetamia.” Mobile health applications can facilitate access to information about symptoms, treatments, and nearby healthcare facilities. Telemedicine services can connect patients with healthcare providers, allowing for remote consultations and reducing the need for travel, especially in emergencies.
In addition, digital platforms can be used for data collection and analysis, helping public health officials track malaria trends and improve resource allocation. Such technological solutions can complement traditional healthcare approaches and enhance the overall response to malaria in Nigeria.
The challenge of “paracetamia” in Nigeria is a symptom of deeper systemic issues within the healthcare system. Tackling malaria requires a comprehensive strategy that includes education, improved healthcare access, and the innovative use of technology. By addressing the root causes of “paracetamia,” Nigeria can better combat malaria and ultimately reduce its impact on public health and economic development. A concerted effort from the government, health organisations, and communities is essential in creating a healthier future for all Nigerians.
What exactly is high blood pressure? Is it a disease or a “dis-ease”? To explore this question, here are three cases from Carib Health Wellness Centre that highlight the issue.
Case #1
The first case involved a 36-year-old gentleman. He was referred to us by his physician for high blood pressure management after failing to respond to therapy. Initially, he had been seen by his doctor about seven to ten days before coming to our attention. At the time, his blood pressure (BP) was over 200 systolic, and his doctor immediately put him on infusions. He was subsequently placed on oral amlodipine, but over the next several days, his BP began rising again. His doctor increased the dose of amlodipine, but the BP shot back up to 200. Very concerned, my colleague physically brought the patient to my clinic.
Upon taking his history, we learned that he works in the Nollywood industry, and many times he is up until three, four, or five in the morning on set, filming.
He eats and drinks whatever is provided, usually fast food, junk food, and sugary soft drinks. His sleeping pattern was highly erratic, a consequence of his work.
After obtaining the history and examining this gentleman, I noted that although he had no headache or chest pains, he felt generally unwell. His systolic BP was 194, and his diastolic was 110. I immediately instructed my staff to prepare for infusions.
While the infusions were being set up, I asked the nurse to give him two fresh young coconuts to consume the coconut water. From his history, it was clear to me that he was chronically dehydrated. He had disrupted his circadian rhythm over a long period and was eating nutrient-deficient foods.
After consuming the first and second coconut water, he requested a third. This confirmed his dehydration. By the time he finished the third coconut water, about an hour or maybe an hour and 15 minutes had passed since he arrived at the clinic. At this point, we had not yet started the infusion.
I then instructed my nurse to check his blood pressure. It was 146 systolic over 80 diastolic. His doctor, who was still present, was pleasantly surprised, as was the patient. At this point, I felt there was no need for the infusion to lower the blood pressure further.
The cause of his high blood pressure was threefold:
Chronic disruption of his normal circadian rhythm due to his work lifestyle.
Chronic dehydration – consuming inadequate amounts of water and instead drinking soft drinks.
Chronic poor nutrition – eating food lacking in micronutrients.
By addressing these causes consistently, the body was able to respond and normalise his blood pressure without medical intervention.
Subsequently, he came to the clinic every day to pick up three coconuts for the water. By the end of the month, his doctor had weaned him off the medication completely.
To this day, he has maintained normal blood pressure. Let me add that during the month he was coming for coconut water, he brought several of his colleagues from the movie industry to our centre, for which we are grateful.
This is a simple example of understanding that high blood pressure is not a disease but rather a state in which the body is no longer at its natural ease. (Continues next edition).
